1
|
Stoks M, Vieco-Martí I, Noguera I, Sánchez-Sánchez M, Burgos-Panadero R, Navarro S, Noguera R. Digital image analysis workflows for evaluation of cell behavior and tumor microenvironment to aid therapeutic assessment in high-risk neuroblastoma. Comput Biol Med 2023; 164:107364. [PMID: 37598482 DOI: 10.1016/j.compbiomed.2023.107364] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2023] [Revised: 08/03/2023] [Accepted: 08/12/2023] [Indexed: 08/22/2023]
Abstract
Digital pathology and artificial intelligence are promising emerging tools in precision oncology as they provide more robust and reproducible analysis of histologic, morphologic and topologic characteristics of tumor cells and the surrounding microenvironment. This study aims to develop digital image analysis workflows for therapeutic assessment in preclinical in vivo models. For this purpose, we generated pipelines that enable automatic detection and quantification of vitronectin and αvβ3 in heterotopic high-risk neuroblastoma xenografts, demonstrating that digital analysis workflows can be used to provide robust detection of vitronectin secretion and αvβ3 expression by malignant neuroblasts and to evaluate the possibility of combining traditional chemotherapy (etoposide) with extracellular matrix-targeted therapies (cilengitide). Digital image analysis added evidence for the relevance of territorial vitronectin as a therapeutic target in neuroblastoma, since its expression is modified after treatment, with a mean percentage of 60.44% in combined therapy tumors vs 45.08% in control ones. In addition, the present study revealed the efficacy of cilengitide for reducing αvβ3 expression, with a mean αvβ3 positivity of 34.17% in cilengitide treated material vs 66.14% in control and with less tumor growth when combined with etoposide, with a final mean volume of 0.04 cm3 in combined therapy vs 1.45 cm3 in control. The results of this work highlight the importance of extracellular matrix-focused therapies in preclinical studies to improve therapeutic assessment for high-risk neuroblastoma patients.
Collapse
Affiliation(s)
- M Stoks
- CIBERONC, Carlos III Health Institute (Ministry of Economy and Competitiveness), 28029, Madrid, Spain
| | - I Vieco-Martí
- CIBERONC, Carlos III Health Institute (Ministry of Economy and Competitiveness), 28029, Madrid, Spain; Department of Pathology, Medical School, University of Valencia - INCLIVA Biomedical Health Research Institute, 46010, Valencia, Spain
| | - I Noguera
- CIBERONC, Carlos III Health Institute (Ministry of Economy and Competitiveness), 28029, Madrid, Spain; Central Support Service for Experimental Research (SCSIE), University of Valencia, Burjassot, Valencia, Spain
| | - M Sánchez-Sánchez
- Department of Pathology, Medical School, University of Valencia - INCLIVA Biomedical Health Research Institute, 46010, Valencia, Spain
| | - R Burgos-Panadero
- CIBERONC, Carlos III Health Institute (Ministry of Economy and Competitiveness), 28029, Madrid, Spain; Department of Pathology, Medical School, University of Valencia - INCLIVA Biomedical Health Research Institute, 46010, Valencia, Spain
| | - S Navarro
- CIBERONC, Carlos III Health Institute (Ministry of Economy and Competitiveness), 28029, Madrid, Spain; Department of Pathology, Medical School, University of Valencia - INCLIVA Biomedical Health Research Institute, 46010, Valencia, Spain
| | - R Noguera
- CIBERONC, Carlos III Health Institute (Ministry of Economy and Competitiveness), 28029, Madrid, Spain; Department of Pathology, Medical School, University of Valencia - INCLIVA Biomedical Health Research Institute, 46010, Valencia, Spain.
| |
Collapse
|
2
|
Uria-Oficialdegui ML, Navarro S, Murillo-Sanjuan L, Rodriguez-Vigil C, Benitez-Carbante MI, Blazquez-Goñi C, Salinas JA, Diaz-de-Heredia C. Dyskeratosis congenita: natural history of the disease through the study of a cohort of patients diagnosed in childhood. Front Pediatr 2023; 11:1182476. [PMID: 37593443 PMCID: PMC10427857 DOI: 10.3389/fped.2023.1182476] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/08/2023] [Accepted: 07/14/2023] [Indexed: 08/19/2023] Open
Abstract
Background Dyskeratosis congenita (DC) is a multisystem and ultra-rare hereditary disease characterized by somatic involvement, bone marrow failure, and predisposition to cancer. The main objective of this study is to describe the natural history of DC through a cohort of patients diagnosed in childhood and followed up for a long period of time. Material and methods Multicenter, retrospective, longitudinal study conducted in patients followed up to 24 years since being diagnosed in childhood (between 1998 and 2020). Results Fourteen patients were diagnosed with DC between the ages of 3 and 17 years (median, 8.5 years). They all had hematologic manifestations at diagnosis, and nine developed mucocutaneous manifestations during the first decade of life. Seven presented severe DC variants. All developed non-hematologic manifestations during follow-up. Mutations were identified in 12 patients. Thirteen progressed to bone marrow failure at a median age of 8 years [range, 3-18 years], and eight received a hematopoietic stem cell transplant. Median follow-up time was 9 years [range, 2-24 years]. Six patients died, the median age was 13 years [range, 6-24 years]. As of November 2022, eight patients were still alive, with a median age of 18 years [range, 6-32 years]. None of them have developed myeloblastic syndrome or cancer. Conclusions DC was associated with high morbidity and mortality in our series. Hematologic manifestations appeared early and consistently. Non-hematologic manifestations developed progressively. No patient developed cancer possibly due to their young age. Due to the complexity of the disease multidisciplinary follow-up and adequate transition to adult care are essential.
Collapse
Affiliation(s)
- M. L. Uria-Oficialdegui
- Pediatric Hematology and Oncology Division, Hospital Universitari Vall d´Hebron, Barcelona, Spain
| | - S. Navarro
- Pediatric Division, Hospital Universitario SonEspases, Palma de Mallorca, Spain
| | - L. Murillo-Sanjuan
- Pediatric Hematology and Oncology Division, Hospital Universitari Vall d´Hebron, Barcelona, Spain
| | - C. Rodriguez-Vigil
- Pediatric Oncohaematology Unit, Paediatric Division, Hospital Universitario Miguel Servet, Zaragoza, Spain
| | - M. I. Benitez-Carbante
- Pediatric Hematology and Oncology Division, Hospital Universitari Vall d´Hebron, Barcelona, Spain
| | | | - J. A. Salinas
- Pediatric Division, Hospital Universitario SonEspases, Palma de Mallorca, Spain
| | - C. Diaz-de-Heredia
- Pediatric Hematology and Oncology Division, Hospital Universitari Vall d´Hebron, Barcelona, Spain
| |
Collapse
|
3
|
Dueñas N, Navarro M, Sanjuán X, Ruiz N, Iglesias S, Matias-Guiu X, Guardiola J, Kreisler E, Biondo S, González S, Legido R, Blanco A, Navarro S, Asiain L, Santos C, Capellá G, Pineda M, Brunet J. Lessons learnt from the implementation of a colorectal cancer screening programme for lynch syndrome in a tertiary public hospital. Cancer Epidemiol 2023; 82:102291. [PMID: 36410089 DOI: 10.1016/j.canep.2022.102291] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2022] [Revised: 11/03/2022] [Accepted: 11/04/2022] [Indexed: 11/19/2022]
Abstract
BACKGROUND Lynch syndrome (LS) is the first cause of inherited colorectal cancer (CRC), being responsible for 2-4% of all diagnoses. Identification of affected individuals is important as they have an increased lifetime risk of multiple CRC and other neoplasms, however, LS is consistently underdiagnosed at the population level. We aimed to evaluate the yield of LS screening in CRC in a single-referral centre and to identify the barriers to its effective implementation. METHODS LS screening programme included individuals with CRC < 70 years, multiple CRC, or endometrial cancer at any age. Mismatch repair (MMR) protein immunohistochemistry (IHC) analysis was performed in routine practice on the surgical specimen and, if MLH1 IHC was altered, MLH1 gene promoter methylation was analysed. Results were collected in the CRC multidisciplinary board database. LS suspected individuals (altered MMR IHC without MLH1 promoter methylation) were referred to the Cancer Genetic Counselling Unit (CGCU). If accepted, a genetic study was performed. Two checkpoints were included: review of the pathology data and verification of patient referral by a genetic counsellor. RESULTS Between 2016 and 2019, 381 individuals were included. MMR IHC analysis was performed in 374/381 (98.2 %) CRC cases and MLH1 promoter methylation in 18/21 (85.7 %). Seventeen of the 20 LS suspected individuals were invited for referral at the CGCU. Two cases were not invited and the remaining patient died of cancer before completion of tumour screening. Fifteen individuals attended and a genetic analysis was performed in 15/20 (75 %) LS suspected individuals. Ten individuals were diagnosed with LS, in concordance with the IHC profile (2.7 % of the total cohort). This led to cascade testing in 58/75 (77.3 %) of the available adult relatives at risk, identifying 26 individuals with LS. CONCLUSIONS Establishing a standardized institutional LS screening programme with checkpoints in the workflow is key to increasing the yield of LS identification.
Collapse
Affiliation(s)
- Nuria Dueñas
- Hereditary Cancer Program, Catalan Institute of Oncology-IDIBELL, ONCOBELL, Hospitalet de Llobregat, 08908 Barcelona, Spain; Biomedical Research Centre Network for Oncology (CIBERONC), Instituto Salud Carlos III, 28029 Madrid, Spain.
| | - Matilde Navarro
- Hereditary Cancer Program, Catalan Institute of Oncology-IDIBELL, ONCOBELL, Hospitalet de Llobregat, 08908 Barcelona, Spain; Hereditary Cancer Program, Catalan Institute of Oncology, Badalona 08916, Barcelona, Spain
| | - Xavier Sanjuán
- Department of Pathology, Bellvitge University Hospital, Hospitalet de Llobregat, 08907 Barcelona, Spain
| | - Núria Ruiz
- Department of Pathology, Bellvitge University Hospital, Hospitalet de Llobregat, 08907 Barcelona, Spain
| | - Silvia Iglesias
- Hereditary Cancer Program, Catalan Institute of Oncology-IDIBELL, ONCOBELL, Hospitalet de Llobregat, 08908 Barcelona, Spain
| | - Xavier Matias-Guiu
- Department of Pathology, Bellvitge University Hospital, Hospitalet de Llobregat, 08907 Barcelona, Spain
| | - Jordi Guardiola
- Department of Gastroenterology, Bellvitge University Hospital, Hospitalet de Llobregat, 08907 Barcelona, Spain
| | - Esther Kreisler
- Department of General Surgery, Bellvitge University Hospital, Hospitalet de Llobregat, 08907 Barcelona, Spain
| | - Sebastiano Biondo
- Department of General Surgery, Bellvitge University Hospital, Hospitalet de Llobregat, 08907 Barcelona, Spain
| | - Sara González
- Hereditary Cancer Program, Catalan Institute of Oncology-IDIBELL, ONCOBELL, Hospitalet de Llobregat, 08908 Barcelona, Spain; Biomedical Research Centre Network for Oncology (CIBERONC), Instituto Salud Carlos III, 28029 Madrid, Spain
| | - Raquel Legido
- Colorectal Cancer Multidisciplinary Board, Catalan Institute of Oncology, Hospitalet de Llobregat, 08908 Barcelona, Spain
| | - Ana Blanco
- Colorectal Cancer Multidisciplinary Board, Bellvitge University Hospital, Hospitalet de Llobregat, 08907 Barcelona, Spain
| | - Silvia Navarro
- Colorectal Cancer Multidisciplinary Board, Bellvitge University Hospital, Hospitalet de Llobregat, 08907 Barcelona, Spain
| | - Leyre Asiain
- Department of Radiation Oncology, Catalan Institute of Oncology, Hospitalet de Llobregat, 08908 Barcelona, Spain
| | - Cristina Santos
- Biomedical Research Centre Network for Oncology (CIBERONC), Instituto Salud Carlos III, 28029 Madrid, Spain; Department of Medical Oncology, Catalan Institute of Oncology, Hospitalet de Llobregat, 08908 Barcelona, Spain; Bellvitge Health Sciences Campus, University of Barcelona, Hospitalet de Llobregat, 08908 Barcelona, Spain
| | - Gabriel Capellá
- Hereditary Cancer Program, Catalan Institute of Oncology-IDIBELL, ONCOBELL, Hospitalet de Llobregat, 08908 Barcelona, Spain; Biomedical Research Centre Network for Oncology (CIBERONC), Instituto Salud Carlos III, 28029 Madrid, Spain
| | - Marta Pineda
- Hereditary Cancer Program, Catalan Institute of Oncology-IDIBELL, ONCOBELL, Hospitalet de Llobregat, 08908 Barcelona, Spain; Biomedical Research Centre Network for Oncology (CIBERONC), Instituto Salud Carlos III, 28029 Madrid, Spain
| | - Joan Brunet
- Hereditary Cancer Program, Catalan Institute of Oncology-IDIBELL, ONCOBELL, Hospitalet de Llobregat, 08908 Barcelona, Spain; Biomedical Research Centre Network for Oncology (CIBERONC), Instituto Salud Carlos III, 28029 Madrid, Spain; Hereditary Cancer Program, Catalan Institute of Oncology-IDIBGI, OncoGir-Pro, 17007 Girona, Spain
| |
Collapse
|
4
|
Murdoch N, Stott AE, Gillier M, Hueso R, Lemmon M, Martinez G, Apéstigue V, Toledo D, Lorenz RD, Chide B, Munguira A, Sánchez-Lavega A, Vicente-Retortillo A, Newman CE, Maurice S, de la Torre Juárez M, Bertrand T, Banfield D, Navarro S, Marin M, Torres J, Gomez-Elvira J, Jacob X, Cadu A, Sournac A, Rodriguez-Manfredi JA, Wiens RC, Mimoun D. The sound of a Martian dust devil. Nat Commun 2022; 13:7505. [PMID: 36513637 PMCID: PMC9747922 DOI: 10.1038/s41467-022-35100-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2022] [Accepted: 11/18/2022] [Indexed: 12/15/2022] Open
Abstract
Dust devils (convective vortices loaded with dust) are common at the surface of Mars, particularly at Jezero crater, the landing site of the Perseverance rover. They are indicators of atmospheric turbulence and are an important lifting mechanism for the Martian dust cycle. Improving our understanding of dust lifting and atmospheric transport is key for accurate simulation of the dust cycle and for the prediction of dust storms, in addition to being important for future space exploration as grain impacts are implicated in the degradation of hardware on the surface of Mars. Here we describe the sound of a Martian dust devil as recorded by the SuperCam instrument on the Perseverance rover. The dust devil encounter was also simultaneously imaged by the Perseverance rover's Navigation Camera and observed by several sensors in the Mars Environmental Dynamics Analyzer instrument. Combining these unique multi-sensorial data with modelling, we show that the dust devil was around 25 m large, at least 118 m tall, and passed directly over the rover travelling at approximately 5 m s-1. Acoustic signals of grain impacts recorded during the vortex encounter provide quantitative information about the number density of particles in the vortex. The sound of a Martian dust devil was inaccessible until SuperCam microphone recordings. This chance dust devil encounter demonstrates the potential of acoustic data for resolving the rapid wind structure of the Martian atmosphere and for directly quantifying wind-blown grain fluxes on Mars.
Collapse
Affiliation(s)
- N. Murdoch
- grid.508721.9Institut Supérieur de l’Aéronautique et de l’Espace (ISAE-SUPAERO), Université de Toulouse, Toulouse, France
| | - A. E. Stott
- grid.508721.9Institut Supérieur de l’Aéronautique et de l’Espace (ISAE-SUPAERO), Université de Toulouse, Toulouse, France
| | - M. Gillier
- grid.508721.9Institut Supérieur de l’Aéronautique et de l’Espace (ISAE-SUPAERO), Université de Toulouse, Toulouse, France
| | - R. Hueso
- grid.11480.3c0000000121671098Física Aplicada, Escuela de Ingeniería de Bilbao, Universidad del País Vasco (UPV/EHU), Bilbao, Spain
| | - M. Lemmon
- grid.296797.40000 0004 6023 5450Space Science Institute, Boulder, CO 80301 USA
| | - G. Martinez
- grid.410493.b0000 0000 8634 1877Lunar and Planetary Institute, Universities Space Research Association, Houston, TX USA ,grid.214458.e0000000086837370Department of Climate and Space Sciences and Engineering, University of Michigan, Ann Arbor, MI USA
| | - V. Apéstigue
- grid.15312.340000 0004 1794 1528Instituto Nacional de Técnica Aeroespacial, Madrid, Spain
| | - D. Toledo
- grid.15312.340000 0004 1794 1528Instituto Nacional de Técnica Aeroespacial, Madrid, Spain
| | - R. D. Lorenz
- grid.474430.00000 0004 0630 1170Space Exploration Sector, Johns Hopkins Applied Physics Laboratory, Laurel, MD USA
| | - B. Chide
- grid.148313.c0000 0004 0428 3079Space and Planetary Exploration Team, Los Alamos National Laboratory, Los Alamos, NM USA
| | - A. Munguira
- grid.11480.3c0000000121671098Física Aplicada, Escuela de Ingeniería de Bilbao, Universidad del País Vasco (UPV/EHU), Bilbao, Spain
| | - A. Sánchez-Lavega
- grid.11480.3c0000000121671098Física Aplicada, Escuela de Ingeniería de Bilbao, Universidad del País Vasco (UPV/EHU), Bilbao, Spain
| | | | | | - S. Maurice
- grid.15781.3a0000 0001 0723 035XInstitut de Recherche en Astrophysique et Planétologie, Université de Toulouse 3 Paul Sabatier, CNRS, CNES, Toulouse, France
| | - M. de la Torre Juárez
- grid.20861.3d0000000107068890Jet Propulsion Laboratory, California Institute of Technology, Pasadena, CA USA
| | - T. Bertrand
- grid.482824.00000 0004 0370 8434Laboratoire d’Etudes Spatiales et d’Instrumentation en Astrophysique (LESIA), Observatoire de Paris, Université PSL, CNRS, Sorbonne Université, Univ. Paris Diderot, Sorbonne Paris Cité, 5 place Jules Janssen, 92195 Meudon, France
| | - D. Banfield
- grid.5386.8000000041936877XCornell University, Ithaca, NY USA ,grid.419075.e0000 0001 1955 7990NASA AMES Research Center, Moffett Field, CA USA
| | - S. Navarro
- grid.462011.00000 0001 2199 0769Centro de Astrobiología (INTA-CSIC), Madrid, Spain
| | - M. Marin
- grid.462011.00000 0001 2199 0769Centro de Astrobiología (INTA-CSIC), Madrid, Spain
| | - J. Torres
- grid.462011.00000 0001 2199 0769Centro de Astrobiología (INTA-CSIC), Madrid, Spain
| | - J. Gomez-Elvira
- grid.15312.340000 0004 1794 1528Instituto Nacional de Técnica Aeroespacial, Madrid, Spain
| | - X. Jacob
- grid.15781.3a0000 0001 0723 035XInstitut de Mécanique des Fluides, Université de Toulouse III Paul Sabatier, INP, CNRS, Toulouse, France
| | - A. Cadu
- grid.508721.9Institut Supérieur de l’Aéronautique et de l’Espace (ISAE-SUPAERO), Université de Toulouse, Toulouse, France
| | - A. Sournac
- grid.508721.9Institut Supérieur de l’Aéronautique et de l’Espace (ISAE-SUPAERO), Université de Toulouse, Toulouse, France
| | | | - R. C. Wiens
- grid.169077.e0000 0004 1937 2197Earth, Atmospheric, and Planetary Sciences, Purdue University, West Lafayette, IN USA
| | - D. Mimoun
- grid.508721.9Institut Supérieur de l’Aéronautique et de l’Espace (ISAE-SUPAERO), Université de Toulouse, Toulouse, France
| |
Collapse
|
5
|
Borges ME, Navarro S, de Paz Carmona H, Esparza P. Natural Volcanic Material as a Sustainable Photocatalytic Material for Pollutant Degradation under Solar Irradiation. Materials 2022; 15:ma15113996. [PMID: 35683289 PMCID: PMC9182453 DOI: 10.3390/ma15113996] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/06/2022] [Revised: 05/27/2022] [Accepted: 06/01/2022] [Indexed: 11/16/2022]
Abstract
Recently, photocatalysis has been demonstrated as a solid approach for efficient wastewater cleaning. Using natural materials as photocatalysts means a promising solution to develop green catalysts for environmental purposes. This work aimed to study the suitability of a natural volcanic material (La Gomera, Canary Islands, Spain) as a photocatalytic material for the degradation of pollutants in wastewater with solar energy. After analysing the properties of the natural material (BET surface 0.188 m2/g and band-gap of 3 eV), the photocatalytic activity was evaluated at laboratory and pilot plant scale for the degradation of methylene blue (MB) in water (50 mg L−1), at 20 °C, during a period of 4 h, under UV/Vis light and solar irradiation. Photolytic and adsorption studies were developed to distinguish the photocatalytic contribution to the wastewater decontamination process by photocatalysis. Our results enable us to determine the viability of black sand as a photocatalytic material activated by solar irradiation (photodegradation of MB up to 100% by using solar energy), developing a natural and green photocatalytic system with significantly high potential for application in a sustainable wastewater cleaning process.
Collapse
Affiliation(s)
- María Emma Borges
- Chemical Engineering Department, University of La Laguna, Avda. Astrofísico Fco. Sánchez s/n, 38200 La Laguna, Tenerife, Spain; (S.N.); (H.d.P.C.)
- Correspondence:
| | - Silvia Navarro
- Chemical Engineering Department, University of La Laguna, Avda. Astrofísico Fco. Sánchez s/n, 38200 La Laguna, Tenerife, Spain; (S.N.); (H.d.P.C.)
| | - Héctor de Paz Carmona
- Chemical Engineering Department, University of La Laguna, Avda. Astrofísico Fco. Sánchez s/n, 38200 La Laguna, Tenerife, Spain; (S.N.); (H.d.P.C.)
| | - Pedro Esparza
- Chemistry Department, University of La Laguna, Avda. Astrofísico Fco. Sánchez s/n, 38200 La Laguna, Tenerife, Spain;
| |
Collapse
|
6
|
Méndez R, Figuerola A, Chicot M, Barrios A, Pascual N, Ramasco F, Rodríguez D, García I, von Wernitz A, Zurita N, Semiglia A, Jiménez D, Navarro S, Rubio MJ, Vinuesa M, Del Campo L, Bautista A, Pizarro A. Sepsis Code: dodging mortality in a tertiary hospital. Rev Esp Quimioter 2022; 35:43-49. [PMID: 34812031 PMCID: PMC8790636 DOI: 10.37201/req/105.2021] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Introducción En el hospital de La Princesa comienza el “Código Sepsis” (CSP) en el año 2015, como un grupo multidisciplinar que dota al personal sanitario de herramientas clínicas, analíticas y organizativas, con el objetivo de la detección y el tratamiento precoz del paciente con sepsis. El objetivo de este estudio es evaluar el impacto de la implantación de CSP en la mortalidad y determinar las variables asociadas con un aumento de la misma. Material y métodos Se realizó un estudio analítico retrospectivo de los pacientes con activación de la alerta CSP de 2015 a 2018. Se recogieron variables clínico-epidemiológicas, parámetros analíticos y factores de gravedad como el ingreso en Unidades de Cuidados Críticos (UCC) y la necesidad de aminas. La significación estadística se estableció en una p < 0,05. Resultados Se incluyeron 1.121 pacientes. La estancia media fue de 16 días y un 32% requirieron ingreso en UCC. La mortalidad mostró una tendencia lineal descendente estadísticamente significativa del 24% en 2015 hasta el 15% en 2018. Las variables predictivas de mortalidad con asociación estadísticamente significativa fueron el lactato > 2 mmol/L, la creatinina > 1,6 mg/dL y la necesidad de aminas. Conclusiones La implementación de Código Sepsis disminuye la mortalidad de los pacientes con sepsis y shock séptico. La presencia de una cifra de lactato > 2 mmol/L, los niveles de creatinina > 1,6 mg/dL y/o la necesidad de administrar aminas en las primeras 24 horas, se asocian con un aumento de la mortalidad en el paciente con sepsis.
Collapse
Affiliation(s)
- R Méndez
- Rosa Méndez Hernández. Servicio de Anestesia y Reanimación. Hospital Universitario de La Princesa. Calle Diego de León 62. 28006. Madrid, Spain.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Aliste M, Garrido I, Hernández V, Flores P, Hellín P, Navarro S, Fenoll J. Assessment of reclaimed agro-wastewater polluted with insecticide residues for irrigation of growing lettuce (Lactuca sativa L) using solar photocatalytic technology. Environ Pollut 2022; 292:118367. [PMID: 34655696 DOI: 10.1016/j.envpol.2021.118367] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/20/2021] [Revised: 10/01/2021] [Accepted: 10/12/2021] [Indexed: 06/13/2023]
Abstract
Scientific literature is full of works studying the removal of different pollutants from water through different Advanced Oxidation Processes (AOPs). Many of them only suggest it is reused for agricultural purposes or for small crops in pots. This study is based on the reuse of reclaimed agricultural wastewater contaminated with four insecticides (chlorantraniliprole, imidacloprid, pirimicarb and thiamethoxam) for growing lettuce in field conditions. First, solar photocatalysis with TiO2/Na2S2O8 was used on a pilot plant in a sunny area (Murcia, SE of Spain) as an environmentally friendly technology to remove insecticide residues and their main reaction intermediates from contaminated water. The necessary fluence (H, kJ m-2) to accomplish 90% removal (H90) ranged from 0.12 to 1212 kJ m-2 for pirimicarb and chlorantraniliprole, respectively. Only six (derived from imidacloprid, pirimicarb and thiametoxam) of 18 transformation intermediate products studied were detected in reclaimed water during the photoperiod (2000 kJ m-2 of accumulated UVA radiation) although all of them were totally photodegraded after a fluence of 1250 kJ m-2. Secondly, reclaimed agro-wastewater was used to irrigate two lettuce crops grown under greenhouse conditions and under agricultural field conditions. In no cases, insecticide residues nor their TIPs were noticed above their respective LOQs (limits of quantification) in soil and lettuce samples (between 0.03 and 0.04 μg kg-1 for pirimicarb and 2.49 and 2.23 μg kg-1 for thiamethoxam, respectively) when they were irrigated with reclaimed water, while residues of the four insecticides and some of their intermediates were found in soil and lettuce by the end of cultivation when they were irrigated with non-reclaimed contaminated water. According to the results, this technology can be applied in a sustainable way, mainly in areas with water scarcity and high solar radiation, contributing to water utilisation in drought areas and the use of renewable energy.
Collapse
Affiliation(s)
- M Aliste
- Sustainability and Quality Group of Fruit and Vegetable Products, Murcian Institute for Agricultural and Environmental Research and Development, C/ Mayor s/n, La Alberca, 30150, Murcia, Spain.
| | - I Garrido
- Sustainability and Quality Group of Fruit and Vegetable Products, Murcian Institute for Agricultural and Environmental Research and Development, C/ Mayor s/n, La Alberca, 30150, Murcia, Spain
| | - V Hernández
- Sustainability and Quality Group of Fruit and Vegetable Products, Murcian Institute for Agricultural and Environmental Research and Development, C/ Mayor s/n, La Alberca, 30150, Murcia, Spain
| | - P Flores
- Sustainability and Quality Group of Fruit and Vegetable Products, Murcian Institute for Agricultural and Environmental Research and Development, C/ Mayor s/n, La Alberca, 30150, Murcia, Spain
| | - P Hellín
- Sustainability and Quality Group of Fruit and Vegetable Products, Murcian Institute for Agricultural and Environmental Research and Development, C/ Mayor s/n, La Alberca, 30150, Murcia, Spain
| | - S Navarro
- Department of Agricultural Chemistry, Geology and Pedology, Faculty of Chemistry, University of Murcia, Campus Universitario de Espinardo, 30100, Murcia, Spain
| | - J Fenoll
- Sustainability and Quality Group of Fruit and Vegetable Products, Murcian Institute for Agricultural and Environmental Research and Development, C/ Mayor s/n, La Alberca, 30150, Murcia, Spain
| |
Collapse
|
8
|
Fossum C, Navarro S, Farias A, Ballas L. Racial Disparities in the Use of Palliative Radiotherapy for Black Patients With Multiple Myeloma in the United States. Int J Radiat Oncol Biol Phys 2021. [DOI: 10.1016/j.ijrobp.2021.07.193] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
9
|
Remior P, Monivas V, Garcia-Rodriguez D, Mirelis JG, Navarro S, Borrego A, Cavero-Gibanel MA, Martinez-Mingo A, Sanchez-Gomez A, Garcia-Gomez S, Mingo S. Correlation between automatic and manual methods of right ventricle and left atrium strain quantification. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
Myocardial strain quantification by speckle-tracking of the right ventricle (RV) and left atrium (LA) can be performed by manual or automatic methods.
Purpose
The objective of our study is to evaluate the degree of correlation between manual measurement method and automatic software used in our imaging laboratory, in a population of healthy individuals and patients with cardiac transthyretin amyloidosis (ATTR).
Methods
Fifty-seven individuals were included, 30 patients with ATTR and 27 healthy volunteers, who underwent a transthoracic echocardiogram (TTE) from January to December 2019. Classic echocardiographic parameters and myocardial deformation were obtained according to the ASE/ EACVI guidelines. Global and free wall longitudinal strain of the RV (RVGLS, RVFWLS) and LA global strain (LAGS) analysis were obtained using speckle-tracking with two different software: QLAB Philips 10.7 and AutoSTRAIN Tomtec. Measurements analysis was performed by two experienced echocardiographers. Correlation and reproducibility analysis was performed using Pearson correlation coefficient (PCC) and intraclass correlation coefficient (ICC), respectively.
Results
Seventy-two percent were male and average age was 63±20 years. Linear correlation of RVGLS, RVFWLS and LAGS measurements with both methods reached statistical significance (table). This correlation was stronger and more reliable in the case of the LAGS. The attached figure shows the correlation between the different software in both groups.
Conclusions
AutoSTRAIN Tomtec automatic measurement method had higher reliability and correlation comparing to manual measurements performed by QLAB 10.7, especially in LA measurements. The obtained results, the application speed and the less operator's dependence of this automatic software support its routine use for RV and LA strain quantification.
Funding Acknowledgement
Type of funding sources: None. Correlation and reproducibility resultsLinear regression lines
Collapse
Affiliation(s)
- P Remior
- University Hospital Puerta de Hierro Majadahonda, Madrid, Spain
| | - V Monivas
- University Hospital Puerta de Hierro Majadahonda, Madrid, Spain
| | | | - J G Mirelis
- University Hospital Puerta de Hierro Majadahonda, Madrid, Spain
| | - S Navarro
- University Hospital Puerta de Hierro Majadahonda, Madrid, Spain
| | - A Borrego
- University Hospital Puerta de Hierro Majadahonda, Madrid, Spain
| | | | | | - A Sanchez-Gomez
- University Hospital Puerta de Hierro Majadahonda, Madrid, Spain
| | - S Garcia-Gomez
- University Hospital Puerta de Hierro Majadahonda, Madrid, Spain
| | - S Mingo
- University Hospital Puerta de Hierro Majadahonda, Madrid, Spain
| |
Collapse
|
10
|
Lucas Guerrero V, Montmany S, Rebasa P, Luna A, Navarro S. SPLENIC ANGIOGRAPHIC EMBOLIZATION IN IV AND V-GRADE SPLENIC INJURIES. DOES IT WORK? OUR EXPERIENCE ON THE MANAGEMENT OF SPLENIC INJURIES IN THE LAST 14 YEARS. Br J Surg 2021. [DOI: 10.1093/bjs/znab160.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
Abstract
INTRODUCTION
Spleen is frequently damaged in abdominal trauma. Patients with splenic injury with hemodynamic instability, peritonism signs or other surgical injuries need emergent surgery. Hemodynamically stable patients are treated conservatively. Splenic embolization is indicated in injuries with blush, pseudoaneurysms or arteriovenous fistulas. It is unclear its indication in IV and V-grade splenic injuries without contrast extravasation.
Our hypothesis is that IV and V-grade splenic injuries embolization decreases conservative treatment failure.
MATERIAL AND METHODS
Retrospective observational study, including all patients with blunt splenic injuries, prospectively included in our registry of polytraumatic patients (>16 years) since 2006.
RESULTS
One hundred and seventy patients have been included since 2006. In 2006-2013, when splenic injuries with active bleeding, pseudoaneurysms or arteriovenous fistulas were embolized, 94 patients were included. 37,2% required surgery and 62,8% conservative treatment. Splenic embolization was performed in 17% of patients who were treated conservatively. Conservative treatment failure was 16,9%: 10 cases out of those who underwent medical treatment (4 required embolization and 6 needed surgery).
From 2014 to the present, when IV and V-grade injuries were included in the indications for embolization, 76 patients have been included. 38,2% required surgery and 61,8% were treated conservatively (40,4% were embolized and the rest were treated medically). One case (3,6%) of those treated medically and another (5,3%) of those embolized failed. Overall failure of conservative treatment was 4,3%.
CONCLUSION
Embolization of IV and V-grade splenic injuries decreases conservative treatment failure from 16,9% to 4,3%.
Collapse
Affiliation(s)
| | - S Montmany
- Hospital Universitario Parc Taulí. Sabadell, Barcelona
| | - P Rebasa
- Hospital Universitario Parc Taulí. Sabadell, Barcelona
| | - A Luna
- Hospital Universitario Parc Taulí. Sabadell, Barcelona
| | - S Navarro
- Hospital Universitario Parc Taulí. Sabadell, Barcelona
| |
Collapse
|
11
|
Rodriguez-Manfredi JA, de la Torre Juárez M, Alonso A, Apéstigue V, Arruego I, Atienza T, Banfield D, Boland J, Carrera MA, Castañer L, Ceballos J, Chen-Chen H, Cobos A, Conrad PG, Cordoba E, del Río-Gaztelurrutia T, de Vicente-Retortillo A, Domínguez-Pumar M, Espejo S, Fairen AG, Fernández-Palma A, Ferrándiz R, Ferri F, Fischer E, García-Manchado A, García-Villadangos M, Genzer M, Giménez S, Gómez-Elvira J, Gómez F, Guzewich SD, Harri AM, Hernández CD, Hieta M, Hueso R, Jaakonaho I, Jiménez JJ, Jiménez V, Larman A, Leiter R, Lepinette A, Lemmon MT, López G, Madsen SN, Mäkinen T, Marín M, Martín-Soler J, Martínez G, Molina A, Mora-Sotomayor L, Moreno-Álvarez JF, Navarro S, Newman CE, Ortega C, Parrondo MC, Peinado V, Peña A, Pérez-Grande I, Pérez-Hoyos S, Pla-García J, Polkko J, Postigo M, Prieto-Ballesteros O, Rafkin SCR, Ramos M, Richardson MI, Romeral J, Romero C, Runyon KD, Saiz-Lopez A, Sánchez-Lavega A, Sard I, Schofield JT, Sebastian E, Smith MD, Sullivan RJ, Tamppari LK, Thompson AD, Toledo D, Torrero F, Torres J, Urquí R, Velasco T, Viúdez-Moreiras D, Zurita S. The Mars Environmental Dynamics Analyzer, MEDA. A Suite of Environmental Sensors for the Mars 2020 Mission. Space Sci Rev 2021; 217:48. [PMID: 34776548 PMCID: PMC8550605 DOI: 10.1007/s11214-021-00816-9] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 03/08/2021] [Indexed: 05/16/2023]
Abstract
NASA's Mars 2020 (M2020) rover mission includes a suite of sensors to monitor current environmental conditions near the surface of Mars and to constrain bulk aerosol properties from changes in atmospheric radiation at the surface. The Mars Environmental Dynamics Analyzer (MEDA) consists of a set of meteorological sensors including wind sensor, a barometer, a relative humidity sensor, a set of 5 thermocouples to measure atmospheric temperature at ∼1.5 m and ∼0.5 m above the surface, a set of thermopiles to characterize the thermal IR brightness temperatures of the surface and the lower atmosphere. MEDA adds a radiation and dust sensor to monitor the optical atmospheric properties that can be used to infer bulk aerosol physical properties such as particle size distribution, non-sphericity, and concentration. The MEDA package and its scientific purpose are described in this document as well as how it responded to the calibration tests and how it helps prepare for the human exploration of Mars. A comparison is also presented to previous environmental monitoring payloads landed on Mars on the Viking, Pathfinder, Phoenix, MSL, and InSight spacecraft.
Collapse
Affiliation(s)
| | | | | | - V. Apéstigue
- Instituto Nacional de Técnica Aeroespacial (INTA), Madrid, Spain
| | - I. Arruego
- Instituto Nacional de Técnica Aeroespacial (INTA), Madrid, Spain
| | - T. Atienza
- Universidad Politécnica de Cataluña, Barcelona, Spain
| | - D. Banfield
- Cornell Center for Astrophysics and Planetary Science, Cornell University, Ithaca, NY USA
| | - J. Boland
- Jet Propulsion Laboratory/California Institute of Technology, Pasadena, CA USA
| | | | - L. Castañer
- Universidad Politécnica de Cataluña, Barcelona, Spain
| | - J. Ceballos
- Instituto de Microelectrónica de Sevilla (US-CSIC), Seville, Spain
| | - H. Chen-Chen
- Universidad del País Vasco (UPV/EHU), Bilbao, Spain
| | - A. Cobos
- CRISA-Airbus, Tres Cantos, Spain
| | | | - E. Cordoba
- Jet Propulsion Laboratory/California Institute of Technology, Pasadena, CA USA
| | | | | | | | - S. Espejo
- Instituto de Microelectrónica de Sevilla (US-CSIC), Seville, Spain
| | - A. G. Fairen
- Centro de Astrobiología (INTA-CSIC), Madrid, Spain
| | | | - R. Ferrándiz
- Centro de Astrobiología (INTA-CSIC), Madrid, Spain
| | - F. Ferri
- Università degli Studi di Padova, Padova, Italy
| | - E. Fischer
- University of Michigan, Ann Arbor, MI USA
| | | | | | - M. Genzer
- Finnish Meteorological Institute, Helsinki, Finland
| | - S. Giménez
- Centro de Astrobiología (INTA-CSIC), Madrid, Spain
| | - J. Gómez-Elvira
- Instituto Nacional de Técnica Aeroespacial (INTA), Madrid, Spain
| | - F. Gómez
- Centro de Astrobiología (INTA-CSIC), Madrid, Spain
| | | | - A.-M. Harri
- Finnish Meteorological Institute, Helsinki, Finland
| | - C. D. Hernández
- Jet Propulsion Laboratory/California Institute of Technology, Pasadena, CA USA
| | - M. Hieta
- Finnish Meteorological Institute, Helsinki, Finland
| | - R. Hueso
- Universidad del País Vasco (UPV/EHU), Bilbao, Spain
| | - I. Jaakonaho
- Finnish Meteorological Institute, Helsinki, Finland
| | - J. J. Jiménez
- Instituto Nacional de Técnica Aeroespacial (INTA), Madrid, Spain
| | - V. Jiménez
- Universidad Politécnica de Cataluña, Barcelona, Spain
| | - A. Larman
- Added-Value-Solutions, Elgoibar, Spain
| | - R. Leiter
- Jet Propulsion Laboratory/California Institute of Technology, Pasadena, CA USA
| | - A. Lepinette
- Centro de Astrobiología (INTA-CSIC), Madrid, Spain
| | | | - G. López
- Universidad Politécnica de Cataluña, Barcelona, Spain
| | - S. N. Madsen
- Jet Propulsion Laboratory/California Institute of Technology, Pasadena, CA USA
| | - T. Mäkinen
- Finnish Meteorological Institute, Helsinki, Finland
| | - M. Marín
- Centro de Astrobiología (INTA-CSIC), Madrid, Spain
| | | | - G. Martínez
- Lunar and Planetary Institute, Houston, TX USA
| | - A. Molina
- Centro de Astrobiología (INTA-CSIC), Madrid, Spain
| | | | | | - S. Navarro
- Centro de Astrobiología (INTA-CSIC), Madrid, Spain
| | | | - C. Ortega
- Added-Value-Solutions, Elgoibar, Spain
| | - M. C. Parrondo
- Instituto Nacional de Técnica Aeroespacial (INTA), Madrid, Spain
| | - V. Peinado
- Centro de Astrobiología (INTA-CSIC), Madrid, Spain
| | - A. Peña
- CRISA-Airbus, Tres Cantos, Spain
| | | | | | | | - J. Polkko
- Finnish Meteorological Institute, Helsinki, Finland
| | - M. Postigo
- Centro de Astrobiología (INTA-CSIC), Madrid, Spain
| | | | | | - M. Ramos
- Universidad de Alcalá, Alcalá de Henares, Spain
| | | | - J. Romeral
- Centro de Astrobiología (INTA-CSIC), Madrid, Spain
| | - C. Romero
- Centro de Astrobiología (INTA-CSIC), Madrid, Spain
| | | | - A. Saiz-Lopez
- Dept. of Atmospheric Chemistry and Climate, Institute of Physical Chemistry Rocasolano, CSIC, Madrid, Spain
| | | | - I. Sard
- Added-Value-Solutions, Elgoibar, Spain
| | - J. T. Schofield
- Jet Propulsion Laboratory/California Institute of Technology, Pasadena, CA USA
| | - E. Sebastian
- Centro de Astrobiología (INTA-CSIC), Madrid, Spain
| | - M. D. Smith
- NASA Goddard Space Flight Center, Greenbelt, MD USA
| | - R. J. Sullivan
- Cornell Center for Astrophysics and Planetary Science, Cornell University, Ithaca, NY USA
| | - L. K. Tamppari
- Jet Propulsion Laboratory/California Institute of Technology, Pasadena, CA USA
| | - A. D. Thompson
- Jet Propulsion Laboratory/California Institute of Technology, Pasadena, CA USA
| | - D. Toledo
- Instituto Nacional de Técnica Aeroespacial (INTA), Madrid, Spain
| | | | - J. Torres
- Centro de Astrobiología (INTA-CSIC), Madrid, Spain
| | - R. Urquí
- Centro de Astrobiología (INTA-CSIC), Madrid, Spain
| | | | | | - S. Zurita
- Centro de Astrobiología (INTA-CSIC), Madrid, Spain
| | | |
Collapse
|
12
|
Fossum C, Navarro S, Farias A, Ballas L. Trends In Use Of Palliative Radiotherapy For Multiple Myeloma In The United States. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.194] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
13
|
Ballas L, Fossum C, Navarro S, Farias A. Disparities In Male Vs Female Oncologic Outcomes Following Bladder Preservation: A Population-Based Cohort Study. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.569] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
14
|
Monivas Palomero V, Remior P, Garcia-Rodriguez D, Garcia-Gomez S, Garcia-Izquierdo E, Borrego A, Navarro S, Martinez Mingo A, Arellano-Serrano C, Oteo J, Garcia-Touchard A, Goicolea J, Hernandez Perez F, Mingo S. Usefulness of strain imaging to determine prognosis in pulmonary hypertension. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.0141] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
Pulmonary hypertension (PH) is defined as mean pulmonary arterial pressure (mPAP) ≥25 mmHg at rest, measured by right heart catheterization (RHC).
Purpose
To describe classical and myocardial deformation echocardiographic parameters in patients with established PH and to identify prognostic variables
Methods
We prospectively enrolled 76 patients with mPAP ≥25 mmHg undergoing RHC between 2017 and 2018. All subjects underwent transthoracic echocardiography (TTE) according to the latest ASE/EACVI guidelines the same day of the RHC. Strain analysis was carried out by speckle-tracking echocardiography (QLAB 10.7, Philips). Clinical events during the follow-up were: acute heart failure hospitalization, cardiac transplant and all-cause mortality.
Results
Mean age was 59±12, 43.4% were women and 49 patients (64.5%) belonged to group 2 of PH. The median follow-up was 288 (ICR 92–534) days. Total number of events was 42 (55.3%, 9 deaths). Variables associated to events are shown in Table 1. All classic LV and RV systolic function and strain parameters were associated with a worse prognosis, being free-wall RV longitudinal strain (RVLS) the only one that remained as a prognostic factor in mutivariate analysis. Other variables associated with a worse prognosis were PCP>15 mmHg and NT-proBNP>1800, the latter being independent predictor of events. The attached figure shows event-free survival curves for the global population divided according to whether or not they belong to group II PH.
Conclusions
Our data highlight the prognostic value of free-wall RVLS and NT-proBNP in patients with established PH. NT-ProBNP was only useful in group II PH while free-wall RVLS identified patients with a higher risk of events in both groups, mainly in patients with heart disease
Free event survival Curves
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- V Monivas Palomero
- University Hospital Puerta de Hierro Majadahonda, Department of Cardiology, Madrid, Spain
| | - P Remior
- University Hospital Puerta de Hierro Majadahonda, Department of Cardiology, Madrid, Spain
| | - D Garcia-Rodriguez
- University Hospital Puerta de Hierro Majadahonda, Department of Cardiology, Madrid, Spain
| | - S Garcia-Gomez
- University Hospital Puerta de Hierro Majadahonda, Department of Cardiology, Madrid, Spain
| | - E Garcia-Izquierdo
- University Hospital Puerta de Hierro Majadahonda, Department of Cardiology, Madrid, Spain
| | - A Borrego
- University Hospital Puerta de Hierro Majadahonda, Department of Cardiology, Madrid, Spain
| | - S Navarro
- University Hospital Puerta de Hierro Majadahonda, Department of Cardiology, Madrid, Spain
| | - A Martinez Mingo
- University Hospital Puerta de Hierro Majadahonda, Department of Cardiology, Madrid, Spain
| | - C Arellano-Serrano
- University Hospital Puerta de Hierro Majadahonda, Department of Cardiology, Madrid, Spain
| | - J.F Oteo
- University Hospital Puerta de Hierro Majadahonda, Department of Cardiology, Madrid, Spain
| | - A Garcia-Touchard
- University Hospital Puerta de Hierro Majadahonda, Department of Cardiology, Madrid, Spain
| | - J.F Goicolea
- University Hospital Puerta de Hierro Majadahonda, Department of Cardiology, Madrid, Spain
| | - F Hernandez Perez
- University Hospital Puerta de Hierro Majadahonda, Department of Cardiology, Madrid, Spain
| | - S Mingo
- University Hospital Puerta de Hierro Majadahonda, Department of Cardiology, Madrid, Spain
| |
Collapse
|
15
|
Aliste M, Garrido I, Flores P, Hellín P, Vela N, Navarro S, Fenoll J. Reclamation of agro-wastewater polluted with thirteen pesticides by solar photocatalysis to reuse in irrigation of greenhouse lettuce grown. J Environ Manage 2020; 266:110565. [PMID: 32314743 DOI: 10.1016/j.jenvman.2020.110565] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/11/2019] [Revised: 02/12/2020] [Accepted: 04/03/2020] [Indexed: 06/11/2023]
Abstract
In Mediterranean countries, reuse of reclaimed water is essential for crop irrigation. The occurrence of pesticides in agro-wastewater may represent a risk for human health and environment owing to their release in soil and translocation to plants. The novelty of this work relies on the reuse of reclaimed agro-wastewater polluted with thirteen pesticides for lettuce irrigation. Removing of pesticide residues in agro-wastewater was carried out using natural sunlight and TiO2/Na2S2O8 in a pilot facility located in Murcia (SE of Spain). The studied pesticides were azoxystrobin, boscalid, chlorpropham, flutolanil, flutriafol, isoxaben, methoxyfenozide, myclobutanil, napropamide, prochloraz, propamocarb, propyzamide and triadimenol, which are commonly used in southeast Spain to treat lettuces grown. Different heterogeneous and homogeneous processes were studied and compared. Previously, the optimization of the process for the selection of the best catalytic system was performed at lab-scale. TiO2+ S2O82- was selected due to the greater effectiveness, achieving almost complete disappearance after about 400 kJ m-2 of cumulative UVA exposure. No significant differences were observed in quality parameters of lettuce grown using treated and non-treated agro-wastewater.
Collapse
Affiliation(s)
- M Aliste
- Sustainability and Quality Group of Fruit and Vegetable Products, Murcia Institute of Agri-Food Research and Development, C/ Mayor s/n, La Alberca, 30150, Murcia, Spain.
| | - I Garrido
- Sustainability and Quality Group of Fruit and Vegetable Products, Murcia Institute of Agri-Food Research and Development, C/ Mayor s/n, La Alberca, 30150, Murcia, Spain
| | - P Flores
- Sustainability and Quality Group of Fruit and Vegetable Products, Murcia Institute of Agri-Food Research and Development, C/ Mayor s/n, La Alberca, 30150, Murcia, Spain
| | - P Hellín
- Sustainability and Quality Group of Fruit and Vegetable Products, Murcia Institute of Agri-Food Research and Development, C/ Mayor s/n, La Alberca, 30150, Murcia, Spain
| | - N Vela
- Applied Technology Group to Environmental Health, Faculty of Health Science, Catholic University of Murcia, Campus de Los Jerónimos, s/n, Guadalupe, 30107, Murcia, Spain
| | - S Navarro
- Department of Agricultural Chemistry, Geology and Pedology, Faculty of Chemistry, University of Murcia, Campus Universitario de Espinardo, 30100, Murcia, Spain
| | - J Fenoll
- Sustainability and Quality Group of Fruit and Vegetable Products, Murcia Institute of Agri-Food Research and Development, C/ Mayor s/n, La Alberca, 30150, Murcia, Spain.
| |
Collapse
|
16
|
Oto J, Plana E, Solmoirago MJ, Fernández-Pardo Á, Hervás D, Cana F, España F, Artoni A, Bucciarelli P, Carrabba G, Navarro S, Merati G, Medina P. microRNAs and Markers of Neutrophil Activation as Predictors of Early Incidental Post-Surgical Pulmonary Embolism in Patients with Intracranial Tumors. Cancers (Basel) 2020; 12:cancers12061536. [PMID: 32545233 PMCID: PMC7353032 DOI: 10.3390/cancers12061536] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2020] [Revised: 06/04/2020] [Accepted: 06/05/2020] [Indexed: 02/06/2023] Open
Abstract
Venous thromboembolism (VTE) is a common complication of cancer that severely increases morbidity and mortality. Patients with intracranial tumors are more likely to develop VTE than patients with cancers at other sites. Conversely, limited tools exist to identify patients with high thrombotic risk. Upon activation, neutrophils release their content through different mechanisms triggering thrombosis. We explored the ability of microRNAs (miRNAs) and plasma markers of neutrophil activation measured before surgery to predict the risk of early post-surgical pulmonary embolism (PE) in glioma and meningioma patients. We recruited and prospectively followed 50 patients with glioma and 50 with meningioma, 34% of whom in each group developed an early objectively-diagnosed post-surgical PE. We measured miRNA expression and neutrophil markers (cell-free DNA, nucleosomes, calprotectin and myeloperoxidase) before surgery. In glioma patients, we adjusted and validated a predictive model for post-surgical PE with 6 miRNAs: miR-363-3p, miR-93-3p, miR-22-5p, miR-451a, miR-222-3p and miR-140-3p (AUC = 0.78; 95% Confidence Interval (CI) [0.63, 0.94]) and another with cfDNA and myeloperoxidase as predictors (AUC = 0.71; 95% CI [0.52, 0.90]). Furthermore, we combined both types of markers and obtained a model with myeloperoxidase and miR-140-3p as predictors (AUC = 0.79; 95% CI [0.64, 0.94]). In meningioma patients we fitted and validated a predictive model with 6 miRNAs: miR-29a-3p, miR-660-5p, miR-331-3p, miR-126-5p, miR-23a-3p and miR-23b-3p (AUC = 0.69; 95% CI [0.52, 0.87]). All our models outperformed the Khorana score. This is the first study that analyzes the capability of plasma miRNAs and neutrophil activation markers to predict early post-surgical PE in glioma and meningioma patients. The estimation of the thrombotic risk before surgery may promote a tailored thromboprophylaxis in a selected group of high-risk patients, in order to minimize the incidence of PE and avoid bleedings.
Collapse
Affiliation(s)
- Julia Oto
- Haemostasis, Thrombosis, Atherosclerosis and Vascular Biology Research Group, Medical Research Institute Hospital La Fe (IIS La Fe), 46026 Valencia, Spain; (J.O.); (E.P.); (M.J.S.); (Á.F.-P.); (F.C.); (F.E.); (S.N.)
| | - Emma Plana
- Haemostasis, Thrombosis, Atherosclerosis and Vascular Biology Research Group, Medical Research Institute Hospital La Fe (IIS La Fe), 46026 Valencia, Spain; (J.O.); (E.P.); (M.J.S.); (Á.F.-P.); (F.C.); (F.E.); (S.N.)
- Angiology and Vascular Surgery Service, La Fe University and Polytechnic Hospital, 46026 Valencia, Spain
| | - María José Solmoirago
- Haemostasis, Thrombosis, Atherosclerosis and Vascular Biology Research Group, Medical Research Institute Hospital La Fe (IIS La Fe), 46026 Valencia, Spain; (J.O.); (E.P.); (M.J.S.); (Á.F.-P.); (F.C.); (F.E.); (S.N.)
| | - Álvaro Fernández-Pardo
- Haemostasis, Thrombosis, Atherosclerosis and Vascular Biology Research Group, Medical Research Institute Hospital La Fe (IIS La Fe), 46026 Valencia, Spain; (J.O.); (E.P.); (M.J.S.); (Á.F.-P.); (F.C.); (F.E.); (S.N.)
| | - David Hervás
- Data Science, Biostatistics and Bioinformatics Unit, Medical Research Institute Hospital La Fe (IIS La Fe), 46026 Valencia, Spain;
| | - Fernando Cana
- Haemostasis, Thrombosis, Atherosclerosis and Vascular Biology Research Group, Medical Research Institute Hospital La Fe (IIS La Fe), 46026 Valencia, Spain; (J.O.); (E.P.); (M.J.S.); (Á.F.-P.); (F.C.); (F.E.); (S.N.)
| | - Francisco España
- Haemostasis, Thrombosis, Atherosclerosis and Vascular Biology Research Group, Medical Research Institute Hospital La Fe (IIS La Fe), 46026 Valencia, Spain; (J.O.); (E.P.); (M.J.S.); (Á.F.-P.); (F.C.); (F.E.); (S.N.)
| | - Andrea Artoni
- A. Bianchi Bonomi Hemophilia and Thrombosis Centre, Fondazione IRCCS Ca’Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy; (A.A.); (P.B.); (G.M.)
| | - Paolo Bucciarelli
- A. Bianchi Bonomi Hemophilia and Thrombosis Centre, Fondazione IRCCS Ca’Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy; (A.A.); (P.B.); (G.M.)
| | - Giorgio Carrabba
- Neurosurgery Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy;
| | - Silvia Navarro
- Haemostasis, Thrombosis, Atherosclerosis and Vascular Biology Research Group, Medical Research Institute Hospital La Fe (IIS La Fe), 46026 Valencia, Spain; (J.O.); (E.P.); (M.J.S.); (Á.F.-P.); (F.C.); (F.E.); (S.N.)
| | - Giuliana Merati
- A. Bianchi Bonomi Hemophilia and Thrombosis Centre, Fondazione IRCCS Ca’Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy; (A.A.); (P.B.); (G.M.)
| | - Pilar Medina
- Haemostasis, Thrombosis, Atherosclerosis and Vascular Biology Research Group, Medical Research Institute Hospital La Fe (IIS La Fe), 46026 Valencia, Spain; (J.O.); (E.P.); (M.J.S.); (Á.F.-P.); (F.C.); (F.E.); (S.N.)
- Correspondence:
| |
Collapse
|
17
|
Garrido I, Flores P, Hellín P, Vela N, Navarro S, Fenoll J. Solar reclamation of agro-wastewater polluted with eight pesticides by heterogeneous photocatalysis using a modular facility. A case study. Chemosphere 2020; 249:126156. [PMID: 32062216 DOI: 10.1016/j.chemosphere.2020.126156] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/28/2019] [Revised: 02/06/2020] [Accepted: 02/07/2020] [Indexed: 06/10/2023]
Abstract
In this work, we have studied the removal of eight pesticides, commonly used in fruit crops, in agro-wastewater generated in commercial farms by the cleaning of trace of phytosanitary products in containers and tanks from treatment equipment. The studied pesticides were acetamiprid, cyproconazole, cyprodinil, difenoconazole, fenhexamid, hexythiazox, myclobutanil and thiamethoxam. The trials were performed in a pilot facility located in Murcia (SE of Spain), using natural sunlight and titanium dioxide (TiO2) in tandem with Na2S2O8. Five photocatalytic treatments were carried out during autumn 2017. Results show that the mean (n = 5) final amount was about 13% of the initial pesticide mass present in agro-wastewater. Therefore, we have proved that this technology could be used for tackling the elimination of pesticide residues in agro-wastewater and has favourable prospects of being applied in the water treatment sector.
Collapse
Affiliation(s)
- I Garrido
- Sustainability and Quality Group of Fruit and Vegetable Products. Murcia Institute of Agri-Food Research and Development, C/ Mayor S/n. La Alberca, 30150, Murcia, Spain.
| | - P Flores
- Sustainability and Quality Group of Fruit and Vegetable Products. Murcia Institute of Agri-Food Research and Development, C/ Mayor S/n. La Alberca, 30150, Murcia, Spain
| | - P Hellín
- Sustainability and Quality Group of Fruit and Vegetable Products. Murcia Institute of Agri-Food Research and Development, C/ Mayor S/n. La Alberca, 30150, Murcia, Spain
| | - N Vela
- Applied Technology Group to Environmental Health, Faculty of Health Science, Catholic University of Murcia, Campus de Los Jerónimos, S/n. Guadalupe, 30107, Murcia, Spain
| | - S Navarro
- Department of Agricultural Chemistry, Geology and Pedology, Faculty of Chemistry, University of Murcia, Campus Universitario de Espinardo, 30100, Murcia, Spain
| | - J Fenoll
- Sustainability and Quality Group of Fruit and Vegetable Products. Murcia Institute of Agri-Food Research and Development, C/ Mayor S/n. La Alberca, 30150, Murcia, Spain
| |
Collapse
|
18
|
García-Alfonso P, García-Carbonero R, García-Foncillas J, Pérez-Segura P, Salazar R, Vera R, Ramón Y Cajal S, Hernández-Losa J, Landolfi S, Musulén E, Cuatrecasas M, Navarro S. Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology. Clin Transl Oncol 2020; 22:1976-1991. [PMID: 32418154 PMCID: PMC7505870 DOI: 10.1007/s12094-020-02357-z] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2019] [Accepted: 04/28/2020] [Indexed: 12/16/2022]
Abstract
In this update of the consensus of the Spanish Society of Medical Oncology (Sociedad Española de Oncología Médica—SEOM) and the Spanish Society of Pathology (Sociedad Española de Anatomía Patológica—SEAP), advances in the analysis of biomarkers in advanced colorectal cancer (CRC) as well as susceptibility markers of hereditary CRC and molecular biomarkers of localized CRC are reviewed. Recently published information on the essential determination of KRAS, NRAS and BRAF mutations and the convenience of determining the amplification of human epidermal growth factor receptor 2 (HER2), the expression of proteins in the DNA repair pathway and the study of NTRK fusions are also evaluated. From the pathological point of view, the importance of analysing the tumour budding and poorly differentiated clusters, and its prognostic value in CRC is reviewed, as well as the impact of molecular lymph node analysis on lymph node staging in CRC. The incorporation of pan-genomic technologies, such as next-generation sequencing (NGS) and liquid biopsy in the clinical management of patients with CRC is also outlined. All these aspects are developed in this guide, which, like the previous one, will remain open to any necessary revision in the future.
Collapse
Affiliation(s)
- P García-Alfonso
- Departament of Medical Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
| | - R García-Carbonero
- Departament of Medical Oncology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), UCM, CNIO, CIBERONC, Madrid, Spain
| | - J García-Foncillas
- Departament of Medical Oncology, Hospital Universitario Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Madrid, Spain
| | - P Pérez-Segura
- Departament of Medical Oncology, Hospital Clínico Universitario San Carlos, CIBERONC, Madrid, Spain
| | - R Salazar
- Departament of Medical Oncology, ICO L'Hospitalet, Oncobell Program (IDIBELL), CIBERONC, Hospitalet de Llobregat, Spain
| | - R Vera
- Departament of Medical Oncology, Complejo Hospitalario de Navarra; Navarrabiomed, IDISNA, Pamplona, Spain
| | - S Ramón Y Cajal
- Department of Pathology, Hospital Universitario Vall D'Hebron, CIBERONC, Barcelona, Spain
| | - J Hernández-Losa
- Department of Pathology, Hospital Universitario Vall D'Hebron, CIBERONC, Barcelona, Spain
| | - S Landolfi
- Department of Pathology, Hospital Universitario Vall D'Hebron, CIBERONC, Barcelona, Spain
| | - E Musulén
- Department of Pathology, Hospital Universitari General de Catalunya, Grupo Quirónsalud, Sant Cugat del Vallès, Spain.,Cancer Epigenetics Group, Institut de Recerca Contra La Leucèmia Josep Carreras, Badalona, Spain
| | - M Cuatrecasas
- Department of Pathology, Hospital Clinic, CIBERehd, Barcelona, Spain
| | - S Navarro
- Department of Pathology, University of Valencia, Hospital Clínico Universitario de Valencia, CIBERONC, Valencia, Spain
| |
Collapse
|
19
|
Rueda Soriano J, Rodríguez Puras MJ, Buendía Fuentes F, Wals Rodríguez A, Osa Sáez A, Pulido I, Agüero Ramón-Llin J, Manso García B, Insa Albert B, Navarro S, Martínez-Dolz L, Gallego P. Time course and predictors for neoaortic root dilatation and neoaortic valve regurgitation during adult life after arterial switch operation. ACTA ACUST UNITED AC 2020; 74:329-336. [PMID: 32402686 DOI: 10.1016/j.rec.2020.01.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2019] [Accepted: 01/31/2020] [Indexed: 10/24/2022]
Abstract
INTRODUCTION AND OBJECTIVES There are limited data on the long-term development of neoaortic root dilatation (NRD) and neoaortic valve regurgitation (AR) after arterial switch operation (ASO) for transposition of the great arteries during adult life. METHODS We performed a retrospective longitudinal analysis of 152 patients older than 15 years who underwent ASO for transposition of the great arteries and who were followed-up for 4.9±3.3 years in 2 referral centers. Sequential changes in body surface-adjusted aortic root dimensions and progression to moderate/severe AR were determined in patients with 2 or more echocardiographic examinations. Risk factors for dilatation were tested by Cox regression to identify predictors of AR progression. RESULTS At baseline, moderate AR was present in 9 patients (5.9%) and severe AR in 4 (2.6%), of whom 3 had required aortic valve surgery. Initially, the median neoaortic root dimension was 20.05±2.4mm/m2, which increased significantly to 20.73±2.8mm/m2 (P <.001) at the end of follow-up. The mean change over time was 0.14mm/m2/y (95%CI, 0.07-0.2). Progressive AR was observed in 20 patients (13.5%) and 6 patients (4%) required aortic valve surgery. Progressive AR was associated with bicuspid valve, AR at baseline, NRD at baseline, and neoaortic root enlargement. Independent predictors were bicuspid valve (HR, 3.3; 95%CI, 1.1-15.2; P=.037), AR at baseline (HR, 5.9; 95%CI, 1.6-59.2; P=.006) and increase in NRD (HR, 4.1 95%CI, 2-13.5; P=.023). CONCLUSIONS In adult life, NRD and AR progress over time after ASO. Predictors of progressive AR are bicuspid valve, AR at baseline, and increase in NRD.
Collapse
Affiliation(s)
- Joaquín Rueda Soriano
- Unidad de Cardiopatías Congénitas del Adulto, Servicio de Cardiología, Hospital Universitari i Politècnic La Fe, CIBERCV, Valencia, Spain.
| | - María José Rodríguez Puras
- Unidad de Cardiopatías Congénitas del Adulto, Servicio de Cardiología, Hospital Universitario Virgen del Rocío, Instituto BioMedicina (IBIS), CIBERCV, Sevilla, Spain
| | - Francisco Buendía Fuentes
- Unidad de Cardiopatías Congénitas del Adulto, Servicio de Cardiología, Hospital Universitari i Politècnic La Fe, CIBERCV, Valencia, Spain
| | - Amadeo Wals Rodríguez
- Unidad de Cardiopatías Congénitas del Adulto, Servicio de Cardiología, Hospital Universitario Virgen del Rocío, Instituto BioMedicina (IBIS), CIBERCV, Sevilla, Spain
| | - Ana Osa Sáez
- Servicio de Cardiología, Hospital Universitari i Politècnic La Fe, CIBERCV, Valencia, Spain
| | - Ildefonso Pulido
- Unidad de Cardiopatías Congénitas del Adulto, Servicio de Radiodiagnóstico, Hospital Universitario Virgen del Rocío, Sevilla, Spain
| | - Jaime Agüero Ramón-Llin
- Servicio de Cardiología, Hospital Universitari i Politècnic La Fe, CIBERCV, Valencia, Spain; Área de Fisiopatología del Miocardio, Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain
| | - Begoña Manso García
- Unidad de Cardiopatías Congénitas del Adulto, Sección de Cardiología Pediátrica, Hospital Infantil Virgen del Rocío, Sevilla, Spain
| | - Beatriz Insa Albert
- Sección de Cardiología Pediátrica, Hospital Universitari i Politècnic La Fe, Valencia, Spain
| | - Silvia Navarro
- Unidad de Cardiopatías Congénitas del Adulto, Servicio de Radiodiagnóstico, Hospital Universitario Virgen del Rocío, Sevilla, Spain
| | - Luis Martínez-Dolz
- Servicio de Cardiología, Hospital Universitari i Politècnic La Fe, CIBERCV, Valencia, Spain
| | - Pastora Gallego
- Unidad de Cardiopatías Congénitas del Adulto, Servicio de Cardiología, Hospital Universitario Virgen del Rocío, Instituto BioMedicina (IBIS), CIBERCV, Sevilla, Spain
| |
Collapse
|
20
|
Oto J, Plana E, Sánchez-González JV, García-Olaverri J, Fernández-Pardo Á, España F, Martínez-Sarmiento M, Vera-Donoso CD, Navarro S, Medina P. Urinary microRNAs: Looking for a New Tool in Diagnosis, Prognosis, and Monitoring of Renal Cancer. Curr Urol Rep 2020; 21:11. [DOI: 10.1007/s11934-020-0962-9] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
|
21
|
Oto J, Fernández-Pardo Á, Miralles M, Plana E, España F, Navarro S, Medina P. Activated protein C assays: A review. Clin Chim Acta 2020; 502:227-232. [DOI: 10.1016/j.cca.2019.11.005] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2019] [Revised: 10/31/2019] [Accepted: 11/04/2019] [Indexed: 01/16/2023]
|
22
|
Plana E, Blanes P, Ramos I, Oto J, Medina P, Solmoirago MJ, Navarro S, Miralles M. Quantification of Plasma Markers of Nets in Patients with Abdominal Aortic Aneurysm. Eur J Vasc Endovasc Surg 2019. [DOI: 10.1016/j.ejvs.2019.09.249] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
23
|
Plana E, Gálvez L, Falcón M, Oto J, Medina P, Navarro S, Fernández-Pardo Á, Miralles M. Quantification of Target Proteins Regulated by Micrornas in Abdominal Aortic Aneurysm Tissue. Eur J Vasc Endovasc Surg 2019. [DOI: 10.1016/j.ejvs.2019.09.246] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
24
|
Martos L, Fernández-Pardo Á, López-Fernández MF, Ibáñez F, Herrero S, Tàssies D, González-Porras JR, Solmoirago MJ, Costa MJ, Reverter JC, Marco P, Roldán V, Lecumberri R, Velasco F, Oto J, Iruin G, Alonso MN, Vayá A, Bonanad S, Ferrando F, Martí E, Cid AR, Plana E, Oña F, Cuesta I, González-López TJ, España F, Medina P, Navarro S. Identification of 58 Mutations (26 Novel) in 94 of 109 Symptomatic Spanish Probands with Protein C Deficiency. Thromb Haemost 2019; 119:1409-1418. [PMID: 31254973 DOI: 10.1055/s-0039-1692440] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
Presently, no data on the molecular basis of hereditary protein C (PC) deficiency in Spain is available. We analyzed the PC gene (PROC) in 109 patients with symptomatic PC deficiency and in 342 relatives by sequencing the 9 PROC exons and their flanking intron regions. In 93 probands, we found 58 different mutations (26 novel). Thirty-seven consisted of a nucleotide change, mainly missense mutations, 1 was a 6-nucleotide insertion causing the duplication of 2 amino acids, and 4 were deletions of 1, 3, 4, and 16 nucleotides. Nine mutations caused type II deficiencies, with the presence of normal antigen levels but reduced anticoagulant activity. Using a PC level of 70% as lowest normal limit, we found no mutations in 16 probands and 25 relatives with PC levels ≤ 70%. On the contrary, 4 probands and 12 relatives with PC levels > 70% carried the mutation identified in the proband. The spectrum of recurrent mutations in Spain is different from that found in the Netherlands, where the most frequent mutations were p.Gln174* and p.Arg272Cys, and is more similar to that found in France, where the most frequent were p.Arg220Gln and p.Pro210Leu. In our study, p.Val339Met (9 families), p.Tyr166Cys (7), p.Arg220Gln (6), and p.Glu58Lys (5) were the most prevalent. This study confirms the considerable heterogeneity of the genetic abnormality in PC deficiencies, and allowed genetic counseling to those individuals whose PC levels were close to the lower limit of the normal reference range.
Collapse
Affiliation(s)
- Laura Martos
- Grupo de Investigación en Hemostasia, Trombosis, Arteriosclerosis y Biología Vascular, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - Álvaro Fernández-Pardo
- Grupo de Investigación en Hemostasia, Trombosis, Arteriosclerosis y Biología Vascular, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | | | | | - Sonia Herrero
- Hospital Universitario de Guadalajara, Guadalajara, Spain
| | | | | | - María J Solmoirago
- Grupo de Investigación en Hemostasia, Trombosis, Arteriosclerosis y Biología Vascular, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - María J Costa
- Complejo Hospitalario Universitario A Coruña, A Coruña, Spain
| | | | - Pascual Marco
- Hospital General Universitario de Alicante, Alicante, Spain
| | - Vanessa Roldán
- Hospital General Universitario Morales Meseguer, Murcia, Spain
| | | | - Francisco Velasco
- Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain
| | - Julia Oto
- Grupo de Investigación en Hemostasia, Trombosis, Arteriosclerosis y Biología Vascular, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - Gemma Iruin
- Hospital de Cruces, Baracaldo, Bilbao, Spain
| | | | - Amparo Vayá
- Grupo de Investigación en Hemostasia, Trombosis, Arteriosclerosis y Biología Vascular, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - Santiago Bonanad
- Grupo de Investigación en Hemostasia, Trombosis, Arteriosclerosis y Biología Vascular, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Hospital Universitario y Politécnico La Fe, Valencia, Spain.,Unidad de Trombosis y Hemostasia, Servicio de Hematología, Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - Fernando Ferrando
- Grupo de Investigación en Hemostasia, Trombosis, Arteriosclerosis y Biología Vascular, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Hospital Universitario y Politécnico La Fe, Valencia, Spain.,Unidad de Trombosis y Hemostasia, Servicio de Hematología, Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | | | - Ana R Cid
- Grupo de Investigación en Hemostasia, Trombosis, Arteriosclerosis y Biología Vascular, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Hospital Universitario y Politécnico La Fe, Valencia, Spain.,Unidad de Trombosis y Hemostasia, Servicio de Hematología, Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - Emma Plana
- Grupo de Investigación en Hemostasia, Trombosis, Arteriosclerosis y Biología Vascular, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - Francisca Oña
- Hospital Universitario de Getafe, Getafe, Madrid, Spain
| | | | - Tomás J González-López
- Hospital Universitario de Burgos y Departamento de Ciencias de la Salud, Universidad de Burgos, Burgos, Spain
| | - Francisco España
- Grupo de Investigación en Hemostasia, Trombosis, Arteriosclerosis y Biología Vascular, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - Pilar Medina
- Grupo de Investigación en Hemostasia, Trombosis, Arteriosclerosis y Biología Vascular, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - Silvia Navarro
- Grupo de Investigación en Hemostasia, Trombosis, Arteriosclerosis y Biología Vascular, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | | |
Collapse
|
25
|
Muñoz-Rodríguez J, Hannaoui N, Domínguez A, Centeno C, Parejo V, Rosado M, Prats J, Navarro S. Impact of the baseline study with penile doppler ultrasound in patients with prostate cancer before radical prostatectomy. Actas Urol Esp 2019; 43:84-90. [PMID: 30360903 DOI: 10.1016/j.acuro.2018.08.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2018] [Revised: 07/31/2018] [Accepted: 08/02/2018] [Indexed: 11/12/2022]
Abstract
INTRODUCTION Given the high prevalence of erectile dysfunction in male population between 40-70 years old and the effect of radical prostatectomy on this domain, it is important to perform a baseline study. MATERIAL AND METHODS Prior radical prostatectomy, erectile function has been assessed prospectively in 112 prostate cancer patients using the erectile function (EF) domain of the International Index of Erectile Function (EF-IIEF), Erectile Hardness Score (EHS) and a penile doppler ultrasound (PDUS). Comorbidities and Charlson index were collected. The EORTC QLQ C-30 and PR-25 tests were administered. RESULTS According to EF-IIEF questionnaire, 50.9% of patients showed normal EF and EHS grade 3-4 erection was achieved in the 75.9%. PDUS was normal only in 28.6% of patients and 51.8% showed arterial insufficiency. We found a significant association (P<.0001) between categorized EF-IIEF (normal, mild/moderate/severe) and the EHS value. Between PDUS (normal vs. pathologic) and EHS (3-4 vs. 1-2) statistically significant association (P=.005) was found. Just 35.3% of patients with EHS 3-4 showed normal PDUS. Correlation between the PDUS and the EF-IIEF (≥26 vs.<26) was statistically significant (P=.043). Moreover, only 38.6% of patients with EF-IIEF≥26 had a normal PDUS. CONCLUSIONS In order to predict EF recovery after surgery, global assessment is required. Solely self-administered tests are not enough. In this baseline study, PDUS can play an important role.
Collapse
|
26
|
Sánchez-Villegas A, Cabrera-Suárez B, Molero P, González-Pinto A, Chiclana-Actis C, Cabrera C, Lahortiga-Ramos F, Florido-Rodríguez M, Vega-Pérez P, Vega-Pérez R, Pla J, Calviño-Cabada MJ, Ortuño F, Navarro S, Almeida Y, Hernández-Fleta JL. Preventing the recurrence of depression with a Mediterranean diet supplemented with extra-virgin olive oil. The PREDI-DEP trial: study protocol. BMC Psychiatry 2019; 19:63. [PMID: 30744589 PMCID: PMC6371613 DOI: 10.1186/s12888-019-2036-4] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/07/2018] [Accepted: 01/25/2019] [Indexed: 02/06/2023] Open
Abstract
BACKGROUND The role of dietary patterns in the prevention of unipolar depression has been analyzed in several epidemiological studies. The primary aims of this study are to determine the effectiveness of an extra-olive oil-enriched Mediterranean diet in reducing the recurrence of depression and improving the symptoms of this condition. METHODS Multicenter, two-arm, parallel-group clinical trial. Arm 1, extra-virgin olive oil Mediterranean diet; Arm 2, control group without nutritional intervention. Dieticians are in charge of the nutritional intervention and regular contact with the participants. Contacts are made through our web platform ( https://predidep.es/participantes/ ) or by phone. Recurrence of depression is assessed by psychiatrists and clinical psychologists through clinical evaluations (semi-structured clinical interviews: Spanish SCID-I). Depressive symptoms are assessed with the Beck Depression Inventory. Information on quality of life, level of physical activity, dietary habits, and blood, urine and stool samples are collected after the subject has agreed to participate in the study and once a year. DISCUSSION To the best of our knowledge, the PREDI-DEP trial is the first ongoing randomized clinical trial designed to assess the role of the Mediterranean diet in the prevention of recurrent depression. It could be a cost-effective approach to avoid recurrence and improve the quality of life of these patients. TRIAL REGISTRATION The study has been prospectively registered in the U.S. National Library of Medicine ( https://clinicaltrials.gov ) with NCT number: NCT03081065.
Collapse
Affiliation(s)
- A. Sánchez-Villegas
- 0000 0004 1769 9380grid.4521.2Nutrition Research Group, Research Institute of Biomedical and Health Sciences, University of Las Palmas de Gran Canaria, Paseo Blas Cabrera Felipe Físico s/n, 35016 Las Palmas de Gran Canaria, Spain ,0000 0000 9314 1427grid.413448.eBiomedical Research Center Network on Obesity and Nutrition (CIBERobn) Physiopathology of Obesity and Nutrition, Institute of Health Carlos III, Madrid, Spain
| | - B. Cabrera-Suárez
- Psychiatry and Clinical Psychology Service, Hospital General de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain
| | - P. Molero
- 0000 0001 2191 685Xgrid.411730.0Department of Psychiatry and Medical Psychology, University Clinic of Navarra, Pamplona, Spain ,IDISNA (Instituto de Investigación Sanitaria de Navarra), Pamplona, Spain
| | - A. González-Pinto
- Psychiatry and Clinical Psychology Service, Hospital Universitario de Alava, Vitoria, Spain ,0000 0000 9314 1427grid.413448.eBiomedical Research Center Network on Mental Health (CIBERsam), Institute of Health Carlos III, Madrid, Spain
| | | | - C. Cabrera
- Psychiatry and Clinical Psychology Service, Hospital General de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain
| | - F. Lahortiga-Ramos
- 0000 0001 2191 685Xgrid.411730.0Department of Psychiatry and Medical Psychology, University Clinic of Navarra, Pamplona, Spain ,IDISNA (Instituto de Investigación Sanitaria de Navarra), Pamplona, Spain
| | - M. Florido-Rodríguez
- Psychiatry and Clinical Psychology Service, Hospital General de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain
| | - P. Vega-Pérez
- Psychiatry and Clinical Psychology Service, Hospital Universitario de Alava, Vitoria, Spain
| | - R. Vega-Pérez
- Psychiatry and Clinical Psychology Service, Hospital General de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain
| | - J. Pla
- 0000 0001 2191 685Xgrid.411730.0Department of Psychiatry and Medical Psychology, University Clinic of Navarra, Pamplona, Spain ,IDISNA (Instituto de Investigación Sanitaria de Navarra), Pamplona, Spain
| | - M. J. Calviño-Cabada
- Psychiatry and Clinical Psychology Service, Hospital General de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain
| | - F. Ortuño
- 0000 0001 2191 685Xgrid.411730.0Department of Psychiatry and Medical Psychology, University Clinic of Navarra, Pamplona, Spain ,IDISNA (Instituto de Investigación Sanitaria de Navarra), Pamplona, Spain
| | - S. Navarro
- Psychiatry and Clinical Psychology Service, Hospital General de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain
| | - Y. Almeida
- Psychiatry and Clinical Psychology Service, Hospital General de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain
| | - J. L. Hernández-Fleta
- Psychiatry and Clinical Psychology Service, Hospital General de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain
| |
Collapse
|
27
|
Cernicharo J, Guélin M, Agúndez M, Pardo JR, Massalkhi S, Fonfría JP, Velilla Prieto L, Quintana-Lacaci G, Marcelino N, Marka C, Navarro S, Kramer C. IRC +10216 as a spectroscopic laboratory: improved rotational constants for SiC 2, its isotopologues, and Si 2C. Astron Astrophys 2018; 618:A4. [PMID: 30429616 PMCID: PMC6231541 DOI: 10.1051/0004-6361/201833335] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
This work presents a detailed analysis of the laboratory and astrophysical spectral data available for 28SiC2, 29SiC2,30SiC2, Si13CC, and Si2C. New data on the rotational lines of these species between 70 and 350 GHz have been obtained with high spectral resolution (195 kHz) with the IRAM 30m telescope in the direction of the circumstellar envelope IRC +10216. Frequency measurements can reach an accuracy of 50 kHz for features observed with a good signal to noise ratio. From the observed astrophysical lines and the available laboratory data new rotational and centrifugal distortion constants have been derived for all the isotopologues of SiC2, allowing to predict their spectrum with high accuracy in the millimeter and submillimeter domains. Improved rotational and centrifugal distortion constants have also been obtained for disilicon carbide, Si2C. This work shows that observations of IRC +10216 taken with the IRAM 30m telescope, with a spectral resolution of 195 kHz, can be used for any molecular species detected in this source to derive, or improve, its rotational constants. Hence, IRC +10216 in addition to be one the richest sources in molecular species in the sky, can also be used as a state-of-the-art spectroscopy laboratory in the millimeter and submillimeter domains.
Collapse
Affiliation(s)
- J. Cernicharo
- Group of Molecular Astrophysics, Instituto de Física Fundamental, CSIC, C/ Serrano 123, E-28006, Madrid, Spain
| | - M. Guélin
- Institut de Radioastronomie Millimétrique, 300 rue de la Piscine, F-38406, Saint Martin d'Hères, France
| | - M. Agúndez
- Group of Molecular Astrophysics, Instituto de Física Fundamental, CSIC, C/ Serrano 123, E-28006, Madrid, Spain
| | - J. R. Pardo
- Group of Molecular Astrophysics, Instituto de Física Fundamental, CSIC, C/ Serrano 123, E-28006, Madrid, Spain
| | - S. Massalkhi
- Group of Molecular Astrophysics, Instituto de Física Fundamental, CSIC, C/ Serrano 123, E-28006, Madrid, Spain
| | - J. P. Fonfría
- Group of Molecular Astrophysics, Instituto de Física Fundamental, CSIC, C/ Serrano 123, E-28006, Madrid, Spain
| | - L. Velilla Prieto
- Group of Molecular Astrophysics, Instituto de Física Fundamental, CSIC, C/ Serrano 123, E-28006, Madrid, Spain
| | - G. Quintana-Lacaci
- Group of Molecular Astrophysics, Instituto de Física Fundamental, CSIC, C/ Serrano 123, E-28006, Madrid, Spain
| | - N. Marcelino
- Group of Molecular Astrophysics, Instituto de Física Fundamental, CSIC, C/ Serrano 123, E-28006, Madrid, Spain
| | - C. Marka
- Instituto de Radioastronomía Milimétrica, Avenida Divina Pastora 7, E-18012, Granada, Spain
| | - S. Navarro
- Instituto de Radioastronomía Milimétrica, Avenida Divina Pastora 7, E-18012, Granada, Spain
| | - C. Kramer
- Instituto de Radioastronomía Milimétrica, Avenida Divina Pastora 7, E-18012, Granada, Spain
| |
Collapse
|
28
|
Perez Fidalgo J, Lopez A, Gambardella V, Navarro S, Iranzo A, Diaz Fernandez N, Tolosa P, Silvestre A, Iriarte Moncho E, Garcia Mora M, De la Paz A, Soler J, Cervantes A. Soft tissue sarcomas (STS) in elder patients: No impact of age on overall survival (OS) in an unselected cohort. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy299.051] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
29
|
Birkenkamp-Demtröder K, Christensen E, Sethi H, Sharma S, Wu HT, Taber A, Agerbæk M, Swenerton R, Salari R, Hafez D, Nordentoft I, Lamy P, Srinivasan R, Balcioglu M, Navarro S, Assaf Z, Zimmermann B, Lin J, Bjerggaard Jensen J, Dyrskjøt L. Longitudinal assessment of multiplex patient-specific ctDNA biomarkers in bladder cancer for diagnosis, surveillance and recurrence. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy269.084] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
30
|
Martos L, Ramón LA, Oto J, Fernández-Pardo Á, Bonanad S, Cid AR, Gruber A, Griffin JH, España F, Navarro S, Medina P. α2-Macroglobulin Is a Significant In Vivo Inhibitor of Activated Protein C and Low APC:α2M Levels Are Associated with Venous Thromboembolism. Thromb Haemost 2018; 118:630-638. [PMID: 29448296 PMCID: PMC6002867 DOI: 10.1055/s-0038-1629902] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
BACKGROUND Activated protein C (APC) is a major regulator of thrombin formation. Two major plasma inhibitors form complexes with APC, protein C inhibitor (PCI) and α1-antitrypsin (α1AT), and these complexes have been quantified by specific enzyme-linked immunosorbent assays (ELISAs). Also, complexes of APC with α2-macroglobulin (α2M) have been observed by immunoblotting. Here, we report an ELISA for APC:α2M complexes in plasma. METHODS Plasma samples were pre-treated with dithiothreitol and then with iodoacetamide. The detection range of the newly developed APC:α2M assay was 0.031 to 8.0 ng/mL of complexed APC. Following infusions of APC in humans and baboons, complexes of APC with α2M, PCI and α1AT were quantified. These complexes as well as circulating APC were also measured in 121 patients with a history of venous thromboembolism (VTE) and 119 matched controls. RESULTS In all the in vivo experiments, α2M was a significant APC inhibitor. The VTE case-control study showed that VTE patients had significantly lower APC:α2M and APC levels than the controls (p < 0.001). Individuals in the lowest quartile of APC:α2M or the lowest quartile of APC had approximately four times more VTE risk than those in the highest quartile of APC:α2M or of APC. The risk increased for individuals with low levels of both parameters. CONCLUSION The APC:α2M assay reported here may be useful to help monitor the in vivo fate of APC in plasma. In addition, our results show that a low APC:α2M level is associated with increased VTE risk.
Collapse
Affiliation(s)
- Laura Martos
- Grupo de Investigación en Hemostasia, Trombosis, Arteriosclerosis y Biología Vascular, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - Luis Andrés Ramón
- Grupo de Investigación en Hemostasia, Trombosis, Arteriosclerosis y Biología Vascular, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - Julia Oto
- Grupo de Investigación en Hemostasia, Trombosis, Arteriosclerosis y Biología Vascular, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - Álvaro Fernández-Pardo
- Grupo de Investigación en Hemostasia, Trombosis, Arteriosclerosis y Biología Vascular, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - Santiago Bonanad
- Grupo de Investigación en Hemostasia, Trombosis, Arteriosclerosis y Biología Vascular, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Hospital Universitario y Politécnico La Fe, Valencia, Spain,Unidad de Trombosis y Hemostasia, Servicio de Hematología, Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - Ana Rosa Cid
- Grupo de Investigación en Hemostasia, Trombosis, Arteriosclerosis y Biología Vascular, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Hospital Universitario y Politécnico La Fe, Valencia, Spain,Unidad de Trombosis y Hemostasia, Servicio de Hematología, Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - Andras Gruber
- Department of Biomedical Engineering, Oregon Health and Science University, Portland, Oregon, United States
| | - John H. Griffin
- Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California, United States
| | - Francisco España
- Grupo de Investigación en Hemostasia, Trombosis, Arteriosclerosis y Biología Vascular, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - Silvia Navarro
- Grupo de Investigación en Hemostasia, Trombosis, Arteriosclerosis y Biología Vascular, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - Pilar Medina
- Grupo de Investigación en Hemostasia, Trombosis, Arteriosclerosis y Biología Vascular, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Hospital Universitario y Politécnico La Fe, Valencia, Spain
| |
Collapse
|
31
|
Plana E, Gálvez L, Medina P, Navarro S, Miralles M. Estudio de selección de microRNA como posibles biomarcadores de aneurisma de aorta abdominal. Angiología 2018. [DOI: 10.1016/j.angio.2017.09.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
32
|
Sakka S, Gaboriau R, Picard J, Redois E, Parchantour G, Sarfaty L, Navarro S, Barreau A. Rob’Autism: How to Change Autistic Social Skills in 20 Weeks. New Trends in Medical and Service Robots 2018. [DOI: 10.1007/978-3-319-59972-4_19] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
|
33
|
Abstract
SummaryThe protein C anticoagulant pathway plays a crucial role as a regulator of the blood clotting cascade. Protein C is activated on the vascular endothelial cell membrane by the thrombin-thrombomodulin complex. Once formed, activated protein C (APC) down-regulates thrombin formation by inactivating factors (F)Va and FVIIIa. Endothelial protein C receptor (EPCR) is able to bind protein C and increase the rate of protein C activation. Normal APC generation depends on the precise assemblage, on the surface of endothelial cells, of thrombin, thrombomodulin, protein C and EPCR.Therefore, any change in the efficiency of this assemblage may cause reduced/increased APC generation and modify the risk of thrombosis. This review highlights the different mutations/polymorphisms reported in the EPCR gene and their association with the risk of thrombosis.
Collapse
|
34
|
Medina P, Bonet E, Navarro S, Martos L, Estellés A, Ferrando F, Vicente V, Bertina RM, España F. Effects of oral anticoagulant therapy and haplotype 1 of the endothelial protein C receptor gene on activated protein C levels. Thromb Haemost 2017; 107:448-57. [DOI: 10.1160/th11-07-0510] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2011] [Accepted: 12/05/2011] [Indexed: 11/05/2022]
Abstract
SummaryOral anticoagulants (OACs) reduce activated protein C (APC) plasma levels less than those of protein C (PC) in lupus erythematosus and cardiac patients. Carriers of the H1 haplotype of the endothelial PC receptor gene (PROCR) have higher APC levels than non-carriers. We aimed to confirm these results in a large group of patients treated with OACs because of venous thromboembolism (VTE) and to assess whether the effect is influenced by the PROCR H1 haplotype. We evaluated APC, PC, and factor (F)II levels in 502 VTE patients (158 with and 344 without OACs) and in 322 healthy individuals. Mean APC, PC and FII levels were significantly lower in OAC patients than in patients not taking OACs. During anticoagulant therapy, the FII/PC ratios were independent of the PC values, whereas APC/FII and APC/PC ratios significantly increased when FII and PC levels decreased. Of the 22 OAC patients carrying the H1H1genotype, 11 (50%) showed APC/PCag ≥2.0 and 10 (45%) APC/ FIIag ratios ≥2.0, whereas for the 49 OAC patients non-carrying the H1 haplotype these figures were 6 (12%) and 4 (8%), respectively (p<0.001). Barium citrate adsorption of plasma from OAC patients showed that most of the circulating free and complexed APC, but only part of PCag, is fully carboxylated. In conclusion, during anticoagulant therapy VT patients have APC levels disproportionately higher than the corresponding PC levels, mainly due to the presence of the PROCR H1 haplotype. Furthermore, a sufficiently carboxylated PC Gla-domain seems to be essential for PC activation in vivo.
Collapse
|
35
|
Ramón-Núñez LA, Martos L, Fernández-Pardo Á, Oto J, Medina P, España F, Navarro S. Comparison of protocols and RNA carriers for plasma miRNA isolation. Unraveling RNA carrier influence on miRNA isolation. PLoS One 2017; 12:e0187005. [PMID: 29077772 PMCID: PMC5659774 DOI: 10.1371/journal.pone.0187005] [Citation(s) in RCA: 30] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2016] [Accepted: 10/11/2017] [Indexed: 12/15/2022] Open
Abstract
microRNAs are promising biomarkers in biological fluids in several diseases. Different plasma RNA isolation protocols and carriers are available, but their efficiencies have been scarcely compared. Plasma microRNAs were isolated using a phenol and column-based procedure and a column-based procedure, in the presence or absence of two RNA carriers (yeast RNA and MS2 RNA). We evaluated the presence of PCR inhibitors and the relative abundance of certain microRNAs by qRT-PCR. Furthermore, we analyzed the association between different isolation protocols, the relative abundance of the miRNAs in the sample, the GC content and the free energy of microRNAs. In all microRNAs analyzed, the addition of yeast RNA as a carrier in the different isolation protocols used gave lower raw Cq values, indicating higher microRNA recovery. Moreover, this increase in microRNAs recovery was dependent on their own relative abundance in the sample, their GC content and the free-energy of their own most stable secondary structure. Furthermore, the normalization of microRNA levels by an endogenous microRNA is more reliable than the normalization by plasma volume, as it reduced the difference in microRNA fold abundance between the different isolation protocols evaluated. Our thorough study indicates that a standardization of pre- and analytical conditions is necessary to obtain reproducible inter-laboratory results in plasma microRNA studies.
Collapse
Affiliation(s)
- Luis A. Ramón-Núñez
- Grupo de Hemostasia, Trombosis, Arteriosclerosis y Biología Vascular, Instituto de Investigación Sanitaria La Fe (IIS La Fe). Hospital Universitario y Politécnico La Fe, Valencia, Spain
- * E-mail: (SN); (LAR-N)
| | - Laura Martos
- Grupo de Hemostasia, Trombosis, Arteriosclerosis y Biología Vascular, Instituto de Investigación Sanitaria La Fe (IIS La Fe). Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - Álvaro Fernández-Pardo
- Grupo de Hemostasia, Trombosis, Arteriosclerosis y Biología Vascular, Instituto de Investigación Sanitaria La Fe (IIS La Fe). Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - Julia Oto
- Grupo de Hemostasia, Trombosis, Arteriosclerosis y Biología Vascular, Instituto de Investigación Sanitaria La Fe (IIS La Fe). Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - Pilar Medina
- Grupo de Hemostasia, Trombosis, Arteriosclerosis y Biología Vascular, Instituto de Investigación Sanitaria La Fe (IIS La Fe). Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - Francisco España
- Grupo de Hemostasia, Trombosis, Arteriosclerosis y Biología Vascular, Instituto de Investigación Sanitaria La Fe (IIS La Fe). Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - Silvia Navarro
- Grupo de Hemostasia, Trombosis, Arteriosclerosis y Biología Vascular, Instituto de Investigación Sanitaria La Fe (IIS La Fe). Hospital Universitario y Politécnico La Fe, Valencia, Spain
- * E-mail: (SN); (LAR-N)
| |
Collapse
|
36
|
Cernicharo J, Agúndez M, Velilla Prieto L, Guélin M, Pardo JR, Kahane C, Marka C, Kramer C, Navarro S, Quintana-Lacaci G, Fonfría JP, Marcelino N, Tercero B, Moreno E, Massalkhi S, Santander-García M, McCarthy MC, Gottlieb CA, Alonso JL. Discovery of methyl silane and confirmation of silyl cyanide in IRC +10216. Astron Astrophys 2017; 606:L5. [PMID: 29142328 PMCID: PMC5683346 DOI: 10.1051/0004-6361/201731672] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
We report the discovery in space of methyl silane, CH3SiH3, from observations of ten rotational transitions between 80 and 350 GHz (Ju from 4 to 16) with the IRAM 30 m radio telescope. The molecule was observed in the envelope of the C-star IRC +10216. The observed profiles and our models for the expected emission of methyl silane suggest that the it is formed in the inner zones of the circumstellar envelope, 1-40 R*, with an abundance of (0.5-1) × 10-8 relative to H2. We also observed several rotational transitions of silyl cyanide (SiH3CN), confirming its presence in IRC +10216 in particular, and in space in general. Our models indicate that silyl cyanide is also formed in the inner regions of the envelope, around 20 R*, with an abundance relative to H2 of 6×10-10. The possible formation mechanisms of both species are discussed. We also searched for related chemical species but only upper limits could be obtained.
Collapse
Affiliation(s)
- J Cernicharo
- Group of Molecular Astrophysics, ICMM, CSIC, C/ Sor Juana Inés de La Cruz 3, 28049 Madrid, Spain
| | - M Agúndez
- Group of Molecular Astrophysics, ICMM, CSIC, C/ Sor Juana Inés de La Cruz 3, 28049 Madrid, Spain
| | - L Velilla Prieto
- Group of Molecular Astrophysics, ICMM, CSIC, C/ Sor Juana Inés de La Cruz 3, 28049 Madrid, Spain
| | - M Guélin
- Institut de Radioastronomie Millimétrique, 300 rue de la Piscine, 38406 St-Martin d'Hères, France
| | - J R Pardo
- Group of Molecular Astrophysics, ICMM, CSIC, C/ Sor Juana Inés de La Cruz 3, 28049 Madrid, Spain
| | - C Kahane
- Université Grenoble Alpes, CNRS, IPAG, 38000 Grenoble, France
| | - C Marka
- Instituto de Radioastronomía Milimétrica, Av. Divina Pastora 7, Local 20, 18012 Granada, Spain
| | - C Kramer
- Instituto de Radioastronomía Milimétrica, Av. Divina Pastora 7, Local 20, 18012 Granada, Spain
| | - S Navarro
- Instituto de Radioastronomía Milimétrica, Av. Divina Pastora 7, Local 20, 18012 Granada, Spain
| | - G Quintana-Lacaci
- Group of Molecular Astrophysics, ICMM, CSIC, C/ Sor Juana Inés de La Cruz 3, 28049 Madrid, Spain
| | - J P Fonfría
- Group of Molecular Astrophysics, ICMM, CSIC, C/ Sor Juana Inés de La Cruz 3, 28049 Madrid, Spain
| | - N Marcelino
- Group of Molecular Astrophysics, ICMM, CSIC, C/ Sor Juana Inés de La Cruz 3, 28049 Madrid, Spain
| | - B Tercero
- Group of Molecular Astrophysics, ICMM, CSIC, C/ Sor Juana Inés de La Cruz 3, 28049 Madrid, Spain
| | - E Moreno
- Group of Molecular Astrophysics, ICMM, CSIC, C/ Sor Juana Inés de La Cruz 3, 28049 Madrid, Spain
| | - S Massalkhi
- Group of Molecular Astrophysics, ICMM, CSIC, C/ Sor Juana Inés de La Cruz 3, 28049 Madrid, Spain
| | - M Santander-García
- Group of Molecular Astrophysics, ICMM, CSIC, C/ Sor Juana Inés de La Cruz 3, 28049 Madrid, Spain
| | - M C McCarthy
- Harvard-Smithsonian Center for Astrophysics, Cambridge, MA 02138, and School of Engineering & Applied Sciences, Harvard University, Cambridge, MA 02138, USA
| | - C A Gottlieb
- Harvard-Smithsonian Center for Astrophysics, Cambridge, MA 02138, and School of Engineering & Applied Sciences, Harvard University, Cambridge, MA 02138, USA
| | - J L Alonso
- Grupo de Espectroscopía Molecular (GEM), Edificio Quifima, Área de Química-Física, Laboratorios de Espectroscopía y Bioespectroscopía, Parque Científico UVa, Unidad Asociada CSIC, Universidad de Valladolid, 47011 Valladolid, Spain
| |
Collapse
|
37
|
Deguchi H, Navarro S, Payne AB, Elias DJ, Dowling NF, Austin HD, España F, Medina P, Hooper WC, Griffin JH. Low level of the plasma sphingolipid, glucosylceramide, is associated with thrombotic diseases. Res Pract Thromb Haemost 2017; 1:33-40. [PMID: 29202121 PMCID: PMC5703432 DOI: 10.1002/rth2.12018] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022] Open
Abstract
Essentials Minor abundance plasma lipids, eg, glucosylceramide, can modulate blood coagulation reactions This lipid was measured in plasmas of 1 myocardial infarction and 2 venous thrombosis populations Low plasma glucosylceramide levels were found in each population compared to matched controls Low plasma glucosylceramide levels are associated with venous and arterial thrombosis
Background One previous pilot study suggested the association of low plasma glucosylceramide (GlcCer) levels with venous thrombosis (VTE) risk. Objective We aimed to confirm and evaluate the association of low plasma GlcCer levels with VTE and myocardial infarction (MI) occurrence, respectively. Patients and Methods We evaluated the association of GlcCer in two independent case‐control studies of Caucasian VTE populations (N=210 and 636) and one case‐control study of Caucasian MI patients (N=345). Result Plasma GlcCer levels in VTE patients were lower compared to controls in two independent VTE populations (5.0 vs 5.8 μg/mL, P=.003 for the Scripps registry, and 5.6 vs 6.0 μg/mL, P=.001 for the Valencia registry, respectively). A low plasma GlcCer level (below tenth percentile of controls) was associated with increased VTE occurrence (odds ratio [OR]=3.7 [95% CI, 1.8‐7.9] for Scripps registry and OR=2.1 [95% CI, 1.3‐3.3] for Valencia registry, respectively). For the MI study, the median GlcCer plasma level was lower in MI patients than in controls (4.3 vs 5.6 μg/mL, P<.001), and a low level of GlcCer (below tenth percentile of control) was associated with higher MI occurrence (OR=7.7, [95% CI, 4.3‐13.8]). Conclusion Lower concentration of GlcCer was associated with VTE occurrence in 2 independent studies and also with MI occurrence in 1 study.
Collapse
Affiliation(s)
- Hiroshi Deguchi
- Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, USA
| | - Silvia Navarro
- Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, USA.,Haemostasis, Thrombosis, Atherosclerosis and Vascular Biology Research Group, La Fe Medical Research Institute, Valencia, Spain
| | - Amanda B Payne
- Rollins School of Public Health, Emory University, Atlanta, GA, USA.,Division of Blood Disorders, Centers for Disease Control and Prevention, Atlanta, GA, USA
| | - Darlene J Elias
- Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, USA.,Scripps Clinic and Scripps Green Hospital, La Jolla, CA, USA
| | - Nicole F Dowling
- Rollins School of Public Health, Emory University, Atlanta, GA, USA.,Division of Blood Disorders, Centers for Disease Control and Prevention, Atlanta, GA, USA
| | - Harland D Austin
- Rollins School of Public Health, Emory University, Atlanta, GA, USA
| | - Francisco España
- Haemostasis, Thrombosis, Atherosclerosis and Vascular Biology Research Group, La Fe Medical Research Institute, Valencia, Spain
| | - Pilar Medina
- Haemostasis, Thrombosis, Atherosclerosis and Vascular Biology Research Group, La Fe Medical Research Institute, Valencia, Spain
| | - W Craig Hooper
- Division of Blood Disorders, Centers for Disease Control and Prevention, Atlanta, GA, USA
| | - John H Griffin
- Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, USA
| |
Collapse
|
38
|
Keränen SR, Frasson M, García-Granero E, Navarro S, Campos S, Jordá E, Esclapez P, García-Botello S, Flor B, Espí A, Cervantes A. Stratification of patients with locally advanced rectal cancer (LARC) treated with preoperative chemoradiation (ChR), according to Valentini's nomograms (VN) and the Neoadjuvant Rectal Score (NAR). External validation in a single Institution. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw370.132] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
39
|
Martos L, Bonanad S, Ramón LA, Cid AR, Bonet E, Corral J, Miralles M, España F, Navarro S, Medina P. A simplified assay for the quantification of circulating activated protein C. Clin Chim Acta 2016; 459:101-104. [DOI: 10.1016/j.cca.2016.05.025] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2016] [Revised: 05/26/2016] [Accepted: 05/27/2016] [Indexed: 10/21/2022]
|
40
|
Abstract
Nongestational, nongonadal, and nonteratoma-related choriocarcinoma is an extremely rare entity. The tumor may be pure or associated with carcinoma. Six cases of primary endometrial carcinomas with the presence of syncytiotrophoblastlike beta-human chorionic gonadotropin (beta-HCG)-positive cells have been reported. We describe a case of endometrial carcinoma in a postmenopausal woman, that was composed almost entirely of syncytiotrophoblastic and cytotrophoblastic elements, except in the areas of lymphatic and myometrial invasion, where the neoplasm expressed a papillary serous carcinoma conformation with numerous psammoma bodies. There was not a clear transition between choriocarcinoma and serous carcinoma components. Immunohistochemically, beta-HCG was strongly positive in trophoblastic cells, whereas papillary areas expressed epithelial membrane antigen. These results suggest a double differentiation from malignant stem cells toward an extraembryonal germinal line and a papillary epithelial line. A poor prognosis is expected for this type of neoplasm with extraembryonic differentiation. In the present case, the histologic subtype of uterine papillary serous carcinoma could be an additional risk factor.
Collapse
Affiliation(s)
- P. Molina
- Department of Pathology, Hospital Clinico Universitario, Medical School, Valencia, Spain
| | - J. V. Torres
- Department of Gynecology and Obstetrics, Hospital Clinico Universitario, Medical School, Valencia, Spain
| | | | - A. Llombart-Bosch
- Department of Pathology, Hospital Clinico Universitario, Medical School, Valencia, Spain
| |
Collapse
|
41
|
Shotar E, Law-Ye B, Di Maria F, Baronnet-Chauvet F, Zeidan S, Psimaras D, Bielle F, Pecquet C, Navarro S, Rosso C, Cohen F, Chiras J, Sourour N, Clarençon F. P-020 Non-Ischemic Cerebral Enhancing (NICE) Lesions Secondary to Endovascular Aneurysm Therapy: Nickel Allergy or Foreign Body Reaction? Reports of Two Cases and Review of the Literature. J Neurointerv Surg 2016. [DOI: 10.1136/neurintsurg-2016-012589.62] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
42
|
Ibarrola-Villava M, Tarazona N, Gambardella V, Mongort C, Navarro S, Garcia-Botello S, Rosello S, Cervantes A, Ribas G. Deregulation of IGF2, FZD10, MAPK3, SMAD4 and SRF expression in colorectal cancer. Eur J Cancer 2016. [DOI: 10.1016/s0959-8049(16)61068-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
43
|
Cardeñosa ML, Fleitas T, Ibarrola-Villava M, Peña-Chilet M, Mongort C, Navarro L, Navarro S, Ribas G, Cervantes A. Methylation profile of candidate genes in gastric cancer with microsatellite instability using high-throughput MALDI-TOF mass array technology: The role of RUNX3 in cancer progression. Eur J Cancer 2016. [DOI: 10.1016/s0959-8049(16)61069-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
44
|
Jubierre L, Soriano A, Planells-Ferrer L, París-Coderch L, Tenbaum SP, Romero OA, Moubarak RS, Almazán-Moga A, Molist C, Roma J, Navarro S, Noguera R, Sánchez-Céspedes M, Comella JX, Palmer HG, Sánchez de Toledo J, Gallego S, Segura MF. BRG1/SMARCA4 is essential for neuroblastoma cell viability through modulation of cell death and survival pathways. Oncogene 2016; 35:5179-90. [PMID: 26996667 DOI: 10.1038/onc.2016.50] [Citation(s) in RCA: 53] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2015] [Revised: 10/29/2015] [Accepted: 02/01/2016] [Indexed: 12/16/2022]
Abstract
Neuroblastoma (NB) is a neoplasm of the sympathetic nervous system, and is the most common solid tumor of infancy. NBs are very heterogeneous, with a clinical course ranging from spontaneous regression to resistance to all current forms of treatment. High-risk patients need intense chemotherapy, and only 30-40% will be cured. Relapsed or metastatic tumors acquire multi-drug resistance, raising the need for alternative treatments. Owing to the diverse mechanisms that are responsible of NB chemoresistance, we aimed to target epigenetic factors that control multiple pathways to bypass therapy resistance. We found that the SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily a, member 4 (SMARCA4/BRG1) was consistently upregulated in advanced stages of NB, with high BRG1 levels being indicative of poor outcome. Loss-of-function experiments in vitro and in vivo showed that BRG1 is essential for the proliferation of NB cells. Furthermore, whole-genome transcriptome analysis revealed that BRG1 controls the expression of key elements of oncogenic pathways such as PI3K/AKT and BCL2, which offers a promising new combination therapy for high-risk NB.
Collapse
Affiliation(s)
- L Jubierre
- Laboratory of Translational Research in Child and Adolescent Cancer. Vall d'Hebron Research Institute (VHIR)-UAB, Barcelona, Spain
| | - A Soriano
- Laboratory of Translational Research in Child and Adolescent Cancer. Vall d'Hebron Research Institute (VHIR)-UAB, Barcelona, Spain
| | | | - L París-Coderch
- Laboratory of Translational Research in Child and Adolescent Cancer. Vall d'Hebron Research Institute (VHIR)-UAB, Barcelona, Spain
| | - S P Tenbaum
- Vall d'Hebron Institut of Oncology (VHIO), Stem Cell and Cancer Laboratory, Barcelona, Spain
| | - O A Romero
- Epigenetic and Cancer Biology Program-PEBC/Bellvitge Biomedical Research Institute-IDIBELL Barcelona, Barcelona, Spain
| | - R S Moubarak
- Cell Signaling and Apoptosis Group, VHIR-UAB, Barcelona, Spain
| | - A Almazán-Moga
- Laboratory of Translational Research in Child and Adolescent Cancer. Vall d'Hebron Research Institute (VHIR)-UAB, Barcelona, Spain
| | - C Molist
- Laboratory of Translational Research in Child and Adolescent Cancer. Vall d'Hebron Research Institute (VHIR)-UAB, Barcelona, Spain
| | - J Roma
- Laboratory of Translational Research in Child and Adolescent Cancer. Vall d'Hebron Research Institute (VHIR)-UAB, Barcelona, Spain
| | - S Navarro
- School of Medicine, University of Valencia, Valencia, Spain
| | - R Noguera
- School of Medicine, University of Valencia, Valencia, Spain
| | | | - J X Comella
- Cell Signaling and Apoptosis Group, VHIR-UAB, Barcelona, Spain
| | - H G Palmer
- Vall d'Hebron Institut of Oncology (VHIO), Stem Cell and Cancer Laboratory, Barcelona, Spain
| | - J Sánchez de Toledo
- Laboratory of Translational Research in Child and Adolescent Cancer. Vall d'Hebron Research Institute (VHIR)-UAB, Barcelona, Spain
| | - S Gallego
- Laboratory of Translational Research in Child and Adolescent Cancer. Vall d'Hebron Research Institute (VHIR)-UAB, Barcelona, Spain
| | - M F Segura
- Laboratory of Translational Research in Child and Adolescent Cancer. Vall d'Hebron Research Institute (VHIR)-UAB, Barcelona, Spain
| |
Collapse
|
45
|
Valverde I, Paolino A, Serrano Gotarredona MP, Navarro S, Romero N, Fernandez-Cruz J. NT-proBNP as a biomarker of right ventricular dilatation and pulmonary regurgitation in Tetralogy of Fallot. J Cardiovasc Magn Reson 2015. [PMCID: PMC4328500 DOI: 10.1186/1532-429x-17-s1-q100] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
|
46
|
Shepherd C, Navarro S, Wangchuk P, Wilson D, Daly NL, Loukas A. Identifying the immunomodulatory components of helminths. Parasite Immunol 2015; 37:293-303. [PMID: 25854639 DOI: 10.1111/pim.12192] [Citation(s) in RCA: 47] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2015] [Accepted: 03/18/2015] [Indexed: 12/13/2022]
Abstract
Immunomodulatory components of helminths offer great promise as an entirely new class of biologics for the treatment of inflammatory diseases. Here, we discuss the emerging themes in helminth-driven immunomodulation in the context of therapeutic drug discovery. We broadly define the approaches that are currently applied by researchers to identify these helminth molecules, highlighting key areas of potential exploitation that have been mostly neglected thus far, notably small molecules. Finally, we propose that the investigation of immunomodulatory compounds will enable the translation of current and future research efforts into potential treatments for autoimmune and allergic diseases, while at the same time yielding new insights into the molecular interface of host-parasite biology.
Collapse
Affiliation(s)
- C Shepherd
- Centre for Biodiscovery and Molecular Development of Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Qld, Australia
| | | | | | | | | | | |
Collapse
|
47
|
Cardeñosa ML, Fleitas T, Navarro S, Mongort C, Roselló S, Gambardella V, Ribas G, Ibarrola Villava M, Cervantes A. 2393 Role of RUNX3 expression in peritumoral infiammatory infiltrate of gastric carcinoma. Eur J Cancer 2015. [DOI: 10.1016/s0959-8049(16)31309-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
48
|
Zanello M, Peyre M, Mokhtari K, Boch A, Capelle L, Carpentier A, Clemenceau S, Karachi C, Navarro S, Nouet A, Reina V, Sanson M, Cornu P, Kalamarides M. Méningiomes multi-récidivants : établissement de critères de réponse thérapeutiques après analyse des cinétiques de croissance et des types de récidive. Neurochirurgie 2014. [DOI: 10.1016/j.neuchi.2014.10.031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
49
|
Fenoll J, Vela N, Garrido I, Pérez-Lucas G, Navarro S. Abatement of spinosad and indoxacarb residues in pure water by photocatalytic treatment using binary and ternary oxides of Zn and Ti. Environ Sci Pollut Res Int 2014; 21:12143-12153. [PMID: 24788933 DOI: 10.1007/s11356-014-2930-8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/07/2014] [Accepted: 04/15/2014] [Indexed: 06/03/2023]
Abstract
The photodegradation of indoxacarb, a broad spectrum foliar insecticide and spinosad, a natural insecticide containing two active ingredients, spinosyn A (major component) and spinosyn D (minor component), was studied in aqueous suspensions of binary (ZnO and TiO2) and ternary (Zn2TiO4 and ZnTiO3) oxides under artificial light (300-460 nm) irradiation. As expected, the influence of the semiconductor materials on the degradation of both was very significant in all cases. Photocatalytic experiments showed that the addition of semiconductors in tandem with Na2S2O8 as electron acceptor strongly improved the removal of indoxacarb and spinosad in water compared with the photolytic tests. The reaction rates significantly increased, especially for the ZnO/Na2S2O8 and TiO2/Na2S2O8 systems. The first-order equation (monophasic model) satisfactorily explained the disappearance process, although it offered no explanation for the small concentrations remaining in the process.
Collapse
Affiliation(s)
- J Fenoll
- Departamento de Calidad y Garantía Alimentaria, Instituto Murciano de Investigación y Desarrollo Agrario y Alimentario (IMIDA), C/Mayor s/n. La Alberca, 30150, Murcia, Spain
| | | | | | | | | |
Collapse
|
50
|
Navarro S, Moleiro V, Molina-Estevez FJ, Lozano ML, Chinchon R, Almarza E, Quintana-Bustamante O, Mostoslavsky G, Maetzig T, Galla M, Heinz N, Schiedlmeier B, Torres Y, Modlich U, Samper E, Río P, Segovia JC, Raya A, Güenechea G, Izpisua-Belmonte JC, Bueren JA. Generation of iPSCs from genetically corrected Brca2 hypomorphic cells: implications in cell reprogramming and stem cell therapy. Stem Cells 2014; 32:436-46. [PMID: 24420904 DOI: 10.1002/stem.1586] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2013] [Revised: 09/02/2013] [Accepted: 09/05/2013] [Indexed: 12/24/2022]
Abstract
Fanconi anemia (FA) is a complex genetic disease associated with a defective DNA repair pathway known as the FA pathway. In contrast to many other FA proteins, BRCA2 participates downstream in this pathway and has a critical role in homology-directed recombination (HDR). In our current studies, we have observed an extremely low reprogramming efficiency in cells with a hypomorphic mutation in Brca2 (Brca2(Δ) (27/) (Δ27)), that was associated with increased apoptosis and defective generation of nuclear RAD51 foci during the reprogramming process. Gene complementation facilitated the generation of Brca2(Δ) (27/) (Δ27) induced pluripotent stem cells (iPSCs) with a disease-free FA phenotype. Karyotype analyses and comparative genome hybridization arrays of complemented Brca2(Δ) (27/) (Δ27) iPSCs showed, however, the presence of different genetic alterations in these cells, most of which were not evident in their parental Brca2(Δ) (27/) (Δ27) mouse embryonic fibroblasts. Gene-corrected Brca2(Δ) (27/) (Δ27) iPSCs could be differentiated in vitro toward the hematopoietic lineage, although with a more limited efficacy than WT iPSCs or mouse embryonic stem cells, and did not engraft in irradiated Brca2(Δ) (27/) (Δ27) recipients. Our results are consistent with previous studies proposing that HDR is critical for cell reprogramming and demonstrate that reprogramming defects characteristic of Brca2 mutant cells can be efficiently overcome by gene complementation. Finally, based on analysis of the phenotype, genetic stability, and hematopoietic differentiation potential of gene-corrected Brca2(Δ) (27/) (Δ) (27) iPSCs, achievements and limitations in the application of current reprogramming approaches in hematopoietic stem cell therapy are also discussed.
Collapse
Affiliation(s)
- S Navarro
- Hematopoietic Innovative Therapies Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBER-ER), Madrid, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|